atraet
recent
year
knowledg
physiolog
pharmacolog
hepat
circul
grown
rapidli
liver
microcircul
uniqu
design
allow
effici
exchang
process
plasma
liver
ceil
even
sever
constraint
impos
upon
system
ie
stress
situat
furthermor
recogn
recent
sinusoid
associ
cell
longer
consid
passiv
structur
ensur
dispers
molecul
liver
repres
sophist
network
protect
regul
parenchym
cell
varieti
mediat
final
vascular
abnorm
promin
featur
number
liver
patholog
process
includ
cirrhosi
liver
cell
necrosi
whether
induc
alcohol
ischemia
endotoxin
viru
chemic
although
clear
whether
vascular
lesion
primari
event
lead
hepatocyt
injuri
main
interest
find
liver
microcircul
could
repres
potenti
target
drug
action
condit
mechan
involv
regul
blood
flow
hepat
circul
incomplet
understood
howev
recent
year
knowledg
physiolog
pharmacolog
hepat
circul
grown
rapidli
furthermor
abnorm
hepat
microcircul
appear
major
determin
physiopatholog
mani
liver
diseas
review
focu
structur
physiolog
role
hepat
circul
particularli
relat
substrat
exchang
liver
metabol
review
effect
pharmacolog
agent
particularli
adrenerg
agent
autacoid
releas
sinusoid
cell
intrahepat
vascular
resist
focu
mainli
data
obtain
recent
isol
perfus
rat
liver
final
examin
natur
alter
liver
circul
cirrhosi
alcohol
liver
diseas
sever
model
acut
liver
injuri
discuss
contribut
modif
diseas
process
liver
dual
blood
suppli
approxim
twothird
blood
perfus
liver
venou
suppli
portal
vein
come
splanchnic
territori
fig
includ
digest
tract
diaphragm
spleen
pancrea
tabl
l
show
rel
contribut
differ
organ
portal
blood
flow
awak
rat
use
microspher
method
onethird
blood
perfus
liver
arteri
provid
hepat
arteri
speci
liver
blood
flow
approxim
mlming
liver
repres
cardiac
output
although
wide
variat
may
ocur
comparison
organ
tabl
show
liver
receiv
largest
fraction
cardiac
output
although
rate
perfus
lower
organ
brain
kidney
term
structur
gener
properti
hepat
arteri
similar
arteri
thu
portal
vein
confer
peculiar
hepat
circul
portal
system
defin
set
vessel
interpos
two
capillari
bed
portal
vascular
bed
interpos
capillari
network
splanchnic
territori
hepat
sinusoid
structur
portal
vein
differ
markedli
vein
valv
lack
flow
revers
sever
patholog
condit
eg
cirrhosi
unlik
venou
system
longitudin
muscl
layer
show
spontan
rhythmic
activ
johansson
ljung
johansson
melland
present
adventitia
phenomenon
account
stretchdepend
myogen
tone
portal
vein
bevan
myogen
tone
affect
complianc
portal
vein
therefor
import
modul
portal
pressur
vivo
liver
innerv
sympathet
parasympathet
nerv
enter
organ
close
associ
hepat
arteri
portal
vein
lautt
sawchenko
friedman
extent
local
adrenerg
cholinerg
nerv
vari
markedli
accord
speci
primat
adrenerg
nerv
extend
deepli
lobul
reach
space
diss
friedman
nerv
end
close
contact
hepatocyt
sinusoid
cell
particularli
perisinusoid
cell
rat
intrahepat
nerv
confin
portal
space
extend
lobul
similar
find
report
dog
friedmann
howev
largest
hepat
vein
innerv
termin
near
inferior
vena
cava
rat
spars
parenchym
innerv
compens
numer
gap
junction
hepatocyt
reilli
et
al
skaar
bier
allow
propag
nervou
signal
lobul
distant
hepatocyt
cholinerg
nerv
also
contact
branch
portal
vein
hepat
arteri
gardemann
jungermann
extent
local
cholinerg
nerv
lobul
less
well
document
rat
cholinerg
neuron
appear
termin
vicin
periport
hepatocyt
reilli
et
al
skaar
bier
norepinephrin
releas
nerv
hepat
sympathet
plexu
use
isol
rat
liver
perfus
constant
pressur
beckh
et
al
shown
stimul
nerv
liver
hilum
around
portal
vein
hepat
arteri
induc
norepinephrin
overflow
perfus
stimul
norepinephrin
product
approxim
liver
take
account
valu
perfus
flow
mlming
liver
give
perfus
norepinephrin
concentr
outflow
rim
concomitantli
sympathet
stimu
lation
induc
product
glucos
lactat
reduct
portal
blood
flow
norepinephrin
releas
decreas
nervou
stimul
preced
administr
norepinephrin
rim
increas
observ
presenc
phentolamin
pm
consist
presenc
presynapt
ct
adrenerg
receptor
norepinephrin
product
decreas
propranoloi
probabl
due
presynapt
adrenerg
receptor
desipramin
inhibitor
norepinephrin
reuptak
augment
norepinephrin
releas
suggest
neuron
reuptak
mechan
uptak
exist
rat
liver
norepinephrin
releas
inhibit
absenc
ca
confirm
norepinephrin
secret
select
stimul
arteri
plexu
induc
significantli
higher
norepinephrin
overflow
select
stimul
portal
plexu
gardemann
et
al
indic
sympathet
innerv
hepat
arteri
dens
portal
vein
data
lee
et
al
norepinephrin
releas
hepat
sympathet
nerv
also
demonstr
speci
vivo
direct
stimul
reflex
sympathet
activ
garceau
et
al
garceau
et
al
yamaguchi
garceau
liver
also
play
major
role
norepinephrin
metabol
elimin
effect
hepat
extract
endogen
norepinephrin
reflect
norepinephrin
product
sympathet
nerv
norepinephrin
elimin
liver
estim
true
hepat
extract
clearanc
norepinephrin
requir
use
label
norepinephrin
denerv
isol
perfus
rat
liver
norepinephrin
hepat
clearanc
rang
mlming
liver
physiolog
rang
concentr
ballet
et
al
valu
close
calcul
studi
goreski
dog
goreski
et
al
liver
estim
esler
man
esler
et
al
estim
norepinephrin
hepatosplanchn
clearanc
repres
total
plasma
norepinephrin
clearanc
esler
et
al
within
liver
portal
vein
hepat
arteri
branch
parallel
number
divis
depend
size
liver
termin
branch
vessel
suppli
blood
hepat
sinusoid
portal
venul
end
directli
sinusoid
howev
hepat
arteriol
join
sinusoid
variou
pathway
fig
bloch
grishan
nopanitay
hirooka
et
al
kardon
kessel
koo
et
al
yamamoto
et
al
rat
suppli
dens
peribiliari
plexu
drain
sinusoid
furthermor
numer
anastomos
hepat
arteriol
portal
venul
arteriol
end
directli
sinusoid
contrast
speci
particularli
man
hepat
arteriol
end
directli
sinusoid
arterioport
anastomos
rare
sinusoid
organ
dens
network
extens
anastomos
connect
portal
venul
hepat
venul
anastomos
frequent
periport
area
fig
gumucio
miller
histolog
studi
show
hepatocyt
organ
unicellular
trabecula
contact
two
sinusoid
therefor
threedimension
space
hepatocyt
line
least
three
sinusoid
length
sinusoid
averag
line
hepatocyt
diamet
sinusoid
averag
gm
periport
area
periven
area
gumucio
miller
rappaport
b
perfus
sinusoid
blood
collect
hepat
venul
larger
branch
end
inferior
vena
cava
fraction
plasma
enter
space
diss
filter
matrix
gel
see
section
drain
lymphat
duct
portal
triad
dumont
vivo
microscopi
liver
use
studi
pattern
distribut
flow
hepat
microcircul
howev
must
emphas
studi
perform
rodent
limit
edg
liver
hepat
arteriol
usual
termin
mccuskey
rappaport
flow
arteriol
intermitt
due
cyclic
contract
termin
arteriol
phenomenon
transmit
sinusoid
mccuskey
mccuskey
et
al
diamet
erythrocyt
white
blood
cell
larger
periport
sinusoid
strong
interact
thu
exist
form
blood
element
sinusoid
line
red
blood
cell
highli
deform
continu
adapt
diamet
sinusoid
contrast
leucocyt
much
rigid
compress
sinusoid
wall
space
diss
transient
plug
vessel
lead
interrupt
revers
flow
via
interconnect
sinusoid
mccuskey
et
al
vivo
microscopi
show
gener
pattern
flow
lobul
resembl
random
dispers
rather
steadi
vectori
motion
heterogen
sinusoid
flow
confirm
wide
variat
red
blood
cell
veloc
sinusoid
measur
vivo
microscopi
msec
koo
et
al
larg
variat
transit
time
estim
dilut
curv
plasma
goreski
sever
structur
model
liver
organ
construct
classic
liver
lobul
describ
kiernan
consid
termin
hepat
venul
drain
polygon
area
parenchyma
whose
corner
occupi
portal
space
sass
liver
acinu
develop
rappaport
clump
parenchyma
orient
around
termin
appar
portal
arteriolar
vessel
fig
accordingli
termin
hepat
venul
drain
peripheri
sever
adjac
acini
whatev
model
linear
arrang
hepatocyt
along
sinusoid
creat
concentr
gradient
plasma
parenchyma
mani
substanc
extract
releas
hepatocyt
gumucio
miller
variat
substrat
concentr
may
explain
function
differ
periport
periven
hepatocyt
note
shape
metabol
zone
differ
accord
model
exampl
liver
lobul
model
periven
region
circular
irregular
shape
ascinu
model
fig
sass
liver
lobul
model
account
better
local
liver
damag
liver
acinu
model
better
adapt
shape
metabol
zone
howev
state
sass
clear
periport
periven
area
togeth
form
continuum
liver
parenchyma
describ
irregular
interdigit
system
region
relat
termin
vessel
plasma
dispers
liver
special
fenestr
capillari
call
sinusoid
sinusoid
separ
hepatocyt
diss
space
contain
extracellular
matrix
fig
recogn
recent
sinusoid
associ
cell
passiv
channel
repres
sophist
cellular
network
control
hepatocellular
function
fig
schemat
draw
function
unit
liver
left
liver
lobul
peripher
pericentr
function
area
discern
orient
concentr
around
central
vein
right
liver
acinu
arrang
metabol
zone
depend
proxim
termin
affer
vessel
therefor
stippl
periven
zone
irregularli
shape
sass
reprint
permiss
author
copyright
holder
plenum
press
new
york
adult
liver
cell
hepatocyt
nonparenchym
cell
nonparenchym
cell
includ
sinusoid
cell
cell
associ
extralobular
vascular
biliari
structur
portal
venul
hepat
arteriol
lymphat
biliari
duct
connect
tissu
nonparenchym
nonsinusoid
cell
repres
liver
cell
hepatocyt
largest
cell
occupi
liver
volum
sinusoid
cell
occupi
remain
repres
extracellular
space
sinusoid
space
diss
space
canalicular
volum
less
liver
volum
sass
four
sinusoid
cell
type
identifi
endotheli
cell
kupffer
cell
fat
store
cell
pit
cell
ec
form
wall
liver
sinusoid
fig
perfor
larg
fenestra
often
arrang
cluster
name
siev
plate
diamet
fenestra
approxim
measur
transmiss
electron
microscopi
rat
poros
sinusoid
fenestr
areasinusoid
area
man
mani
speci
wiss
et
al
ec
surround
basal
lamina
characterist
enabl
dispers
plasma
space
diss
convect
rather
diffus
schafer
andreoli
goreski
fenestra
contract
influenc
hormon
mediat
gendrault
et
al
wiss
et
al
howev
evid
phenomenon
significantli
affect
exchang
liver
least
normal
condit
shown
sinusoid
ec
express
function
kupffer
cell
fahimi
summerfield
jone
particular
high
endocytot
activ
dan
wake
praaningvan
dalen
et
al
steffan
et
al
produc
thromboxan
prostaglandin
eyhorn
et
al
kuiper
et
al
role
sinusoid
ec
coagul
unknown
recent
data
suggest
synthes
factor
viii
eyhorn
et
al
mediat
reilli
et
al
reilli
et
al
mechan
phenomenon
unclear
could
induc
contract
fatstor
cell
rather
ec
burridg
grega
majno
et
al
bioulacsag
et
al
kc
macrophag
fix
ec
protrud
sinusoid
lumen
move
across
endotheli
barrier
fig
kc
predomin
periport
region
repres
resid
macrophag
bodi
kc
show
tremend
receptormedi
nonspecif
endocytot
activ
dan
wake
kolbbachofen
et
al
play
major
role
uptak
destruct
foreign
particl
mainli
microorgan
bacteri
endotoxin
kc
express
class
ii
major
histocompat
antigen
play
major
role
initi
immun
respons
graft
reject
fahimi
kc
activ
numer
agent
includ
interferon
endotoxin
plateletactiv
factor
paf
phorbol
ester
zymosan
ca
ionophor
dieter
et
al
respons
includ
releas
cytokin
interleukin
tumor
necrosi
factor
ct
tnf
interleukin
hepatocyt
stimul
factor
fl
interferon
transform
growth
factor
lipid
mediat
paf
prostaglandin
leukotrien
birmelin
decker
brouwer
et
al
hagmann
keppler
kuiper
et
al
ouwendijk
et
al
sakagami
et
al
oxygenderiv
free
radic
final
lysosom
enzym
pattern
respons
depend
stimul
agent
exampl
product
superoxid
induc
zymosan
phorbol
myrist
acet
endotoxin
ca
ionophor
dieter
et
al
product
tnfct
select
stimul
endotoxin
factor
releas
activ
kc
may
interact
secondarili
microcircul
andor
hepatocyt
induc
vasoconstrict
glucos
product
synthesi
acutephas
protein
cell
necrosi
mechan
discuss
detail
later
fatstor
cell
fsc
ito
cell
perisinusoid
cell
lipocyt
locat
space
diss
sometim
insert
adjac
hepatocyt
fig
bioulacsag
balabaud
bioulacsag
et
al
fsc
contain
numer
intracytoplasm
fat
droplet
made
vitamin
store
retinyl
ester
hendrik
et
al
cell
bodi
prolong
long
process
extend
space
diss
surround
endotheli
cell
fsc
contain
complex
cytoskeleton
recent
shown
human
liver
cell
close
nerv
end
suggest
fsc
may
contract
regul
flow
microcircul
bioulacsag
et
al
fsc
synthes
secret
collagen
constitu
extracellular
matrix
play
major
role
develop
fibrosi
arenson
et
al
gresner
haerman
fibrosi
fsc
transform
myofibroblast
migrat
pericentr
region
contribut
increas
intrahepat
portal
resist
see
section
rudolph
et
al
pit
cell
pc
pc
locat
sinusoid
lumen
contact
ec
kc
fig
pc
contain
characterist
intracytoplasm
granul
rod
vesicl
morpholog
pc
ident
nk
cell
pit
cell
show
spontan
cytotox
may
repres
defens
system
tumor
virusinfect
cell
bioulacsag
et
al
sinusoid
separ
hepatocyt
space
diss
although
optic
empti
space
diss
contain
major
compon
extracellular
matrix
ecm
ie
collagen
thin
bundl
type
vi
glycosaminoglycan
heparan
sulfat
glycoprotein
mainli
fibronectin
martinezhernandez
normal
condit
continu
basement
membran
surround
ec
small
amount
collagen
iv
laminin
found
martinezhernandez
interestingli
liverspecif
ecm
compon
identifi
yet
ecm
play
import
role
cell
adhes
b
cell
differenti
multipl
phenotyp
express
c
elast
sinusoid
resist
compress
forc
water
solut
exchang
granger
et
al
glycosaminoglycan
form
hydrat
gel
pore
filter
molecul
accord
size
charg
estim
pore
size
liver
interstitium
suggest
equival
pore
radii
barrowman
et
al
space
diss
connect
peripheri
lobul
space
mall
liver
lymphat
dumont
develop
hepat
fibrosi
associ
mark
increas
amount
collagen
compon
emc
deposit
space
diss
signific
amount
collagen
type
iv
laminin
synthes
result
format
continu
basement
membran
surround
sinusoid
martinez
hernandez
suggest
develop
perisinusoid
fibrosi
could
act
barrier
normal
exchang
nutrient
metabolit
across
diss
space
see
section
howev
view
en
face
basement
membran
appear
like
widemesh
net
imperm
barrier
also
propos
fibrosi
could
disrupt
normal
cellmatrix
relationship
phenotyp
express
cell
hemodynam
properti
liver
microvasculatur
assess
studi
relationship
flow
pressur
intrahepat
vascular
resist
relationship
vascular
volum
pressur
intrahepat
vascular
complianc
anoth
import
aspect
liver
microcircul
regul
plasma
solut
exchang
across
sinusoid
final
recogn
recent
sinusoid
associ
cell
releas
varieti
mediat
potent
vasoact
metabol
properti
follow
section
differ
aspect
liver
microcircul
examin
accord
poisseuil
law
appli
ideal
fluid
constant
temperatur
nondistens
tube
relationship
flow
q
pressur
p
ap
x
nr
q
l
ap
pressur
gradient
extrem
tube
r
radiu
l
length
viscos
equat
indic
flow
relat
pressur
constant
gr
therefor
pressureflow
relationship
theoret
linear
function
intercept
origin
analog
ohm
flow
possibl
defin
resist
r
arbitrarili
ap
r
q
thu
r
deriv
function
p
f
q
easili
calcul
invers
slope
pressureflow
curv
substitut
eq
eq
r
r
relationship
indic
resist
depend
mainli
radiu
vessel
accessorili
length
viscos
pressureflow
curv
intercept
origin
intercept
pressur
axi
defin
zero
flow
pressur
critic
closur
pressur
mitzner
fig
valu
pressur
would
induc
flow
system
usual
low
pressur
flow
valu
pressureflow
curv
becom
curvilinear
toward
pressur
axi
indic
pressur
increas
resist
decreas
phenomenon
interpret
indic
increas
crosssect
area
vessel
result
either
passiv
elast
distens
vessel
andor
increas
number
open
parallel
channel
distribut
close
pressur
accord
latter
model
zero
flow
pressur
correspond
close
pressur
last
vessel
collaps
flow
stop
mitzner
mitzner
extrapol
linear
part
curv
pressur
axi
weight
arithmet
mean
close
pressur
therefor
pressureflow
curv
theoret
possibl
determin
whether
vasoact
agent
affect
resist
andor
critic
closur
pressur
greenway
et
al
pressureflow
relationship
hepat
arteri
approxim
linear
studi
suggest
autoregul
mechan
curvilinear
toward
flow
axi
indic
increas
resist
flow
augment
minim
condon
et
al
intercept
curv
pressur
axi
posit
indic
critic
close
pressur
accord
mitzner
approxim
mm
hg
richardson
withrington
similarli
pressureflow
relationship
portal
venou
system
linear
rang
physiolog
pressur
autoregul
phenomenon
pressur
rise
curvilinear
toward
pressur
axi
observ
low
pressur
posit
intercept
pressur
axi
indic
sinusoid
close
pressur
approxim
vivo
condon
et
al
richardson
withrington
brauer
et
al
studi
pressureflow
relationship
portal
venou
system
isol
rat
liver
perfus
constant
pressur
curv
curvilinear
toward
pressur
axi
perfus
pressur
pressur
higher
cm
pressureflow
curv
becam
linear
brauer
data
possibl
estim
zeroflow
pressur
around
cm
liver
perfus
plasma
cm
perfus
whole
rat
blood
ht
accord
brauer
observ
curvilinear
consist
distribut
sinusoid
critic
close
pressur
cm
progress
recruit
pressur
increas
brauer
et
al
data
import
understand
relationship
flow
metabol
activ
liver
model
predict
number
perfus
sinusoid
depend
flow
accordingli
variat
flow
significantli
affect
liver
function
studi
confirm
result
recent
use
isol
rat
liver
perfus
constant
flow
erythrocytefre
medium
grossman
bhatal
found
critic
close
pressur
mm
hg
curvilinear
pressur
flow
curv
thu
observ
pressur
far
physiolog
rang
clearli
studi
need
clarifi
point
flow
hepat
arteri
control
resist
arteriol
arteriolar
resist
high
indic
pressur
gradient
arteri
mm
hg
sinusoid
vivo
portal
flow
regul
intrahepat
portal
resist
splanchnic
resist
control
blood
flow
splanchnic
territori
similarli
portal
pressur
depend
mainli
portal
flow
complianc
portal
venou
system
appear
less
affect
portal
resist
least
physiolog
condit
indic
low
pressur
gradient
portal
vein
mm
hg
hepat
vein
mm
hg
portal
resist
time
lower
arteri
resist
richardson
withrington
interest
phenomenon
liver
reciproc
relationship
hepat
arteri
portal
vein
lautt
lautt
portal
flow
decreas
resist
hepat
arteri
decreas
therefor
arteri
flow
increas
convers
portal
flow
increas
arteri
resist
decreas
flow
hepat
arteri
decreas
howev
accord
investig
true
reciproc
relationship
sinc
variat
hepat
arteri
flow
affect
portal
flow
respons
call
hepat
arteri
buffer
respons
lautt
lautt
mechan
might
account
phenomenon
present
unknown
complet
extrins
denerv
elimin
respons
select
adenosin
antagonist
inhibitori
effect
suggest
mechan
could
mediat
adenosin
ezzat
lautt
lautt
et
al
buffer
respons
may
complic
studi
vasoact
agent
hepat
circul
sinc
respons
hepat
arteri
may
secondari
direct
effect
arteri
resist
indirect
effect
portal
blood
flow
mechan
could
account
increas
hepat
arteri
flow
observ
cirrhosi
portocav
shunt
intrahepat
vascular
resist
regul
numer
factor
sympathet
parasympathet
nerv
releas
neurotransmitt
norepinephrin
atp
acetylcholin
b
circul
vasoact
hormon
eg
angiotensin
ii
vasopressin
glucagon
c
vasoact
mediat
releas
sinusoid
cell
effect
nervou
stimul
vasoact
agent
liver
circul
vivo
extens
studi
review
data
obtain
anesthet
dog
cat
greenway
stark
lautt
richardson
withrington
princip
regul
intrahepat
vascular
resist
sympathet
nerv
sympathet
stimul
electr
stimul
hepat
perivascular
plexu
reflex
nervou
activ
system
administr
norepinephrin
increas
hepat
arteri
resist
portal
resist
portal
pressur
greenway
et
al
lautt
greenway
richardson
withrington
b
b
increas
portal
pressur
result
increas
portal
resist
reduct
complianc
portal
territori
effect
portal
flow
less
clear
portal
flow
respons
depend
mainli
intens
vasoconstrict
splanchnic
territori
may
vari
accord
experiment
condit
isol
perfus
liver
increasingli
use
studi
effect
hepat
nerv
stimul
vasoact
mediat
intrahepat
vascular
resist
experiment
model
mani
advantag
vivo
studi
allow
studi
intrahepat
vascular
respons
without
interfer
hepat
arteri
splanchnic
system
effect
therefor
enabl
one
determin
vasoact
mediat
direct
effect
hepat
microcircul
b
permit
direct
measur
hepat
blood
flow
c
allow
construct
pressureflow
curv
enabl
studi
high
concentr
agent
avoid
system
toxic
effect
complet
doserespons
curv
therefor
construct
howev
import
emphas
major
limit
model
ie
experi
usual
exceed
hr
progress
deterior
liver
function
b
liver
denerv
c
difficult
perfus
arteri
small
anim
although
differ
system
perfus
liver
hepat
arteri
portal
vein
recent
report
ahmad
et
al
gardemann
et
al
reichen
follow
section
present
overview
data
obtain
isol
rat
liver
perfus
portal
vein
norepinephrin
epinephrin
phenylephrin
increas
intrahepat
vascular
resist
isol
perfus
rat
liver
respons
studi
differ
experiment
condit
ie
constant
pressur
vs
constant
flow
system
singlepass
vs
recircul
system
without
erythrocyt
andor
albumin
perfus
medium
complet
doserespons
curv
obtain
studi
hem
et
al
studi
effect
epinephrin
constant
pressur
system
contain
rat
erythrocyt
doserespons
curv
possibl
estim
minim
effect
concentr
mec
x
concentr
correspond
halfmaxim
effect
around
grossman
bhatal
studi
respons
norepinephrin
use
recircul
constantflow
system
contain
albumin
without
erythrocyt
doserespons
curv
mec
fall
around
era
x
approxim
sm
studi
doserespons
effect
norepinephrin
epinephrin
isol
rat
liver
perfus
constant
pressur
medium
contain
rat
whole
blood
dilut
krebsring
bicarbon
buffer
marteau
ballet
unpublish
data
tabl
mec
era
x
deriv
norepinephrin
doserespons
curv
x
respect
valu
similar
obtain
grossman
bhatal
regard
epinephrin
correspond
valu
x
anoth
studi
found
portal
resist
affect
physiolog
dose
norepinephrin
ballet
et
al
three
dose
norepinephrin
perfus
data
ballet
et
al
marteau
ballet
unpublish
data
plasma
norepinephrin
concentr
portal
vein
determin
radioenzymat
method
ngml
x
x
ngml
x
ra
first
two
concentr
two
extrem
physiolog
rang
cryer
darlington
et
al
woolf
et
al
doselepend
increas
resist
observ
ballet
et
al
emphas
sever
studi
mec
norepinephrin
higher
rang
hartmann
et
al
although
reason
discrep
unclear
vivo
norepinephrin
show
vasoconstrict
activ
canin
skelet
muscl
hjemdahl
et
al
signific
respons
obtain
smooth
muscl
vitro
bevan
howev
must
born
mind
decreas
respons
catecholamin
could
result
photooxid
norepinephrin
perfus
medium
furthermor
albumin
could
modifi
norepinephrin
activ
induc
variat
respons
final
product
activ
metabolit
norepinephrin
could
potenti
respons
norepinephrin
recircul
system
effect
noguchi
plaa
shown
normetanephrin
metanephrin
vasoconstrict
properti
although
activ
less
norepinephrin
epinephrin
use
singlepass
system
constant
flow
shown
norepinephrin
perfus
induc
increas
resist
similar
obtain
recircul
system
vs
howev
escap
phenomenon
occur
singlepass
system
min
recircul
system
ballet
huet
unpublish
data
effect
norepinephrin
resist
antagon
phentolamin
agreement
data
literatur
show
respons
norepinephrin
mediat
adrenerg
receptor
ballet
et
al
propranolol
effect
norepinephrin
doserespons
curv
ballet
et
al
significantli
increas
em
x
doserespons
curv
epinephrin
furthermor
administr
propranolol
ema
x
epinephrin
significantli
differ
norepinephrin
marteau
ballet
unpublish
data
indic
lower
efficaci
epinephrin
compar
norepinephrin
result
flagonist
activ
tend
antagon
adrenerg
respons
basal
condit
ie
without
adrenerg
stimul
isoproterenol
nonselect
terbutalin
select
reduc
intrahepat
resist
respect
confirm
fladrenerg
receptor
exist
hepat
microcircul
howev
isoproterenol
significantli
modifi
respons
norepinephrin
marteau
ballet
unpublish
data
vasoconstrict
induc
adrenerg
stimul
could
result
stimul
either
l
receptor
langer
hick
langer
armstrong
shown
doserespons
curv
paramet
lagonist
phenylephrin
significantli
differ
norepinephrin
tabl
cqagonist
clonidin
uk
induc
dosedepend
vasoconstrict
ie
rang
select
howev
max
clonidin
uk
respect
much
lower
phenylephrin
tabl
norepinephrineinduc
vasoconstrict
antagon
dosedepend
fashion
yohimbin
antagonist
prazosin
concentr
two
antagonist
inhibit
norepinephrin
respons
significantli
differ
x
respect
true
max
respect
howev
yohimbin
ec
higher
prazosin
marteau
ballet
unpublish
data
marteau
et
al
data
show
receptor
present
intrahepat
microcircul
contribut
vasoconstrict
produc
norepinephrin
howev
densiti
emax
lower
adrenoreceptor
therefor
contribut
less
norepinephrineinduc
vasoconstrict
corrobor
find
segstro
greenway
receptor
mediat
contract
hepat
blood
volum
induc
cat
sympathet
activ
effect
variou
class
vasodil
norepinephrineinduc
vasoconstrict
studi
marteau
et
al
adrenerg
antagonist
ifenprodil
isoxsuprin
buflomedil
b
nonselect
fladrenerg
antagonist
propranolol
c
nonselect
fladrenerg
agonist
isoproterenol
czadrenerg
agonist
clonidin
e
calcium
channel
blocker
verapamil
diltiazem
f
nitrovasodil
nitroglycerin
sodium
nitroprussid
g
drug
miscellan
mode
action
papaverin
diazoxid
vincamin
cinepazid
phentolamin
ballet
et
al
ji
et
al
ballet
et
al
prazosin
marteau
ballet
unpublish
data
yohimbin
hartmann
et
al
clonidin
marteau
et
al
grossmann
bhathal
ifenprodil
noguchi
plaa
isoxuprin
buftomedil
nitroprussid
hartmann
et
al
nitroglycerin
diazoxid
pentoxifyllin
papaverin
hartmann
et
al
phenylephrin
nitroprussid
haussing
et
al
b
allopurinol
hill
olson
cytochalasin
fisher
et
al
dieter
et
al
phenylarsin
oxid
steinhelp
olson
haussing
et
al
steinhelp
olson
epinephrin
prazosin
mendlov
et
al
mendlov
et
al
ndga
hem
et
al
bpb
sympathet
stimul
phentolamin
hartmann
et
al
prazosin
puschel
et
al
hartmann
et
al
ca
deplet
hartmann
et
al
haussing
et
al
nifedipin
iwai
et
al
indomethacin
iwai
jungermann
bpb
nitroprussid
hartmann
et
al
haussing
et
al
haussing
et
al
papaverin
hartmann
et
al
atp
ca
deplet
buxton
et
al
buxton
et
al
nitroprussid
papaverin
haussing
et
al
haussing
et
al
indomethacin
iwai
jungermann
haussing
stehl
ndga
iwai
jungermann
bpb
txa
antagonist
bm
haussing
stehl
phenylarsin
oxid
buxton
et
al
utp
haussing
et
al
noguchi
plaa
haussing
et
al
adenosin
buxton
et
al
arachidon
acid
dieter
et
al
paf
buxton
et
al
haussing
et
al
haussing
stehl
et
al
haussing
et
al
haussing
et
al
buxton
et
al
steinhelp
olson
dieter
et
al
buxton
et
al
mendlov
et
al
altin
et
al
mendlov
et
al
altin
et
al
buxton
et
al
fisher
et
al
hill
olson
steinhelp
olson
steinhelp
olson
continu
zymosan
dieter
et
al
heataggreg
igg
buxton
et
al
complement
fraction
puschel
et
al
kci
hill
olson
nifedipin
iwai
et
al
hill
olson
steinhelp
olson
naftidofuryi
pentoxifyllin
potent
drug
ifenprodil
phentolamin
isoxsuprin
clonidin
sodium
nitroprussid
buflomedil
diazoxid
papaverin
pentoxifyllin
trinitrin
effect
lesser
degre
verapamil
diltiazem
propranolol
isoproterenol
vincamin
cinepazid
naphtidofuryl
ineffect
effect
clonidin
could
relat
partial
agonist
activ
postsynapt
receptor
pentoxifyllin
known
rheolog
properti
howev
low
hematocrit
level
use
studi
effect
probabl
small
lack
effect
naphtidofuryl
may
explain
predomin
effect
serotonin
type
agonist
interest
find
lack
effect
calcium
antagonist
wherea
sodium
nitroprussid
effect
inhibitori
effect
sodium
nitroprussid
tadrenerg
respons
confirm
studi
hartmann
et
al
haussing
et
al
b
norepinephrineinduc
contract
isol
portal
vein
rat
vitro
shown
inhibit
calcium
channel
blocker
sodium
nitroprussid
jetley
weston
indic
function
properti
intrahepat
portal
vessel
differ
extrahepat
portal
vein
infer
data
ca
channel
lack
hepat
microcircul
calcium
channel
blocker
thought
inhibit
voltagedepend
ca
channel
activ
norepinephrin
cauvin
van
breeman
godfrind
kamp
miller
van
zwieten
timmerman
howev
shown
recent
least
experiment
system
ca
channel
blocker
also
inhibit
receptordepend
ca
channel
particularli
stimul
cauvin
et
al
thu
ineffici
ca
channel
blocker
suggest
receptorlepend
ca
channel
involv
norepinephrineinduc
vasoconstrict
hepat
microcircul
mechan
may
occur
eg
ca
mobil
intracellular
pool
activ
protein
kinas
c
exton
exton
exton
rasmunsen
b
presenc
voltagedepend
ca
channel
hepat
microcircul
suggest
vasoconstrict
induc
potassium
chlorid
high
concentr
mm
isol
perfus
rat
liver
howev
discrep
respons
kclinduc
vasoconstrict
ca
antagonist
studi
taylor
et
al
verapamil
diltiazem
ineffect
nifedipin
pm
show
signific
activ
studi
hill
colleagu
hill
et
ak
verapamil
cobalt
chlorid
signific
activ
nifedipin
nm
u
ineffect
discuss
kclinduc
interestingli
shown
isol
perfus
kidney
norepinephrineinduc
vasoconstrict
inhibit
diltiazem
nitrendipin
nisoldipin
agent
complet
antagon
kclinduc
vasoconstrict
epstein
mechan
may
involv
ctagonistinduc
vasoconstrict
demonstr
recent
intrahepat
vasoconstrict
induc
phenylephrin
concentr
antagon
phenylarsin
oxid
trival
arsen
deriv
complex
vicin
thiol
inhibit
vesicular
transport
steinhelp
olson
b
effect
phenylarsin
oxid
demonstr
low
concentr
affect
energet
metabol
oxygen
consumpt
suggest
inhibit
cellular
process
depend
vesicular
transport
receptormedi
endocytosi
could
affect
tagonistinduc
vasoact
respons
recent
hill
olson
shown
allopurinol
pm
xanthin
oxidas
inhibitor
abl
antagon
kci
mm
phenylephrin
u
induc
liver
vasoconstrict
preliminari
experi
found
allopurinol
abl
inhibit
norepinephrineinduc
vasoconstrict
chazouillrr
ballet
unpublish
data
howev
effect
obtain
high
allopurinol
concentr
x
data
interpret
suggest
oxygenderiv
free
radic
produc
xanthin
oxidas
could
part
mediat
vasoconstrict
hill
olson
xanthin
oxidas
might
activ
vasoconstrict
via
ischemiareperfus
mechan
although
remain
demonstr
howev
high
concentr
allopurinol
also
signific
free
radic
scaveng
properti
could
therefor
inactiv
free
radic
gener
system
xanthin
oxidas
eg
autoxid
catecholamin
respons
sympathet
stimul
extens
studi
isol
perfus
rat
liver
group
jungermann
grttingen
jungermann
et
al
beckh
et
al
beuer
et
al
ji
et
al
puschel
et
al
sannemann
et
al
bipolar
platinum
electrod
place
around
portal
vein
hepat
arteri
nerv
stimul
perform
appli
rectangular
monophas
impuls
nerv
stimul
increas
intrahepat
vascular
resist
ie
increas
pressur
constant
flow
decreas
flow
constant
pressur
respons
maxim
min
stimul
decreas
even
stimul
maintain
indic
escap
phenomenon
gardemann
et
al
studi
effect
separ
stimul
arteri
venou
portal
plexu
arteri
portal
resist
stimul
arteri
plexu
increas
portal
artecircul
rial
resist
respons
stronger
portal
stimul
reflect
higher
densiti
arteri
nervou
plexu
interestingli
respons
obtain
joint
portal
arteri
stimul
differ
significantli
liver
perfus
portal
vein
alon
portal
vein
hepat
arteri
vasoconstrict
induc
nervou
stimul
antagon
phentolamin
prazosin
propranolol
atropin
pm
ineffect
result
show
vascular
respons
mediat
cqadrenerg
receptor
hepat
cholinerg
nerv
influenc
significantli
sympathet
vascular
respons
latter
inhibit
extraceilular
ca
level
lower
mm
howev
emphas
condit
norepinephrin
releas
also
supress
papaverin
mm
sodium
nitroprussid
also
significantli
inhibit
vascular
sympathet
respons
tabl
circul
vasoact
hormon
number
circul
vasoact
hormon
shown
modul
intrahepat
portal
resist
review
richardson
withrington
isol
perfus
rat
liver
shown
angiotensin
ii
significantli
increas
portal
resist
hem
et
al
howev
doserespons
curv
angiotensin
ii
bellshap
suggest
escap
phenomenon
vasopressin
also
increas
intrahepat
resist
ema
x
lower
angiotensin
ii
hem
et
al
tabl
section
examin
effect
seri
agent
elicit
vasoconstrict
via
mediat
releas
sinusoid
cell
plateletactiv
factor
paf
alkyl
phospholipid
produc
act
varieti
cell
type
includ
neutrophil
eosinophil
monocyt
macrophag
platelet
endotheli
cell
paf
exhibit
broad
spectrum
biolog
effect
addit
potent
activ
platelet
leucocyt
induc
smooth
muscl
contract
dramat
increas
vascular
permeabl
paf
implic
sever
patholog
process
includ
inflamm
ischemia
braquet
et
al
mendlov
et
al
show
paf
induc
vasoconstrict
isol
perfus
rat
liver
effect
inhibit
bromophenacyl
bromid
bpb
phospholipas
inhibitor
indomethacin
cyclooxygenas
inhibitor
significantli
reduc
nordihydroguaiaret
acid
ndga
inhibitor
data
subsequ
confirm
other
altin
et
al
buxton
et
al
b
result
suggest
pafinduc
vasoconstrict
might
mediat
prostaglandin
andor
leukotrien
form
arachidon
acid
releas
sinusoid
cell
inde
vitro
studi
shown
paf
stimul
product
rat
kupffer
cell
paf
alon
appear
stimul
cysteinyl
leukotrien
product
kupffer
cell
howev
significantli
potenti
secret
cysteinyl
leukotrien
elicit
ca
ionophor
aa
sakagami
et
al
subsequ
shown
varieti
agent
known
stimul
kupffer
cell
vitro
induc
vasoconstrict
isol
perfus
rat
liver
phorbol
myrist
acet
pma
patel
tran
thi
et
al
b
zymosan
dieter
et
al
heataggreg
igg
buxton
et
al
complement
fraction
puschel
et
al
increas
intrahepat
vascular
resist
isol
perfus
rat
liver
respons
elicit
agent
suppress
inhibitor
biosynthesi
antagonist
prostaglandin
thromboxan
andor
leukotrien
respons
pma
inhibit
txa
antagonist
bm
cg
tran
thi
et
al
vasoconstrict
induc
heataggreg
igg
inhibit
indomethacin
buxton
et
al
respons
zymosan
significantli
reduc
bpb
indomethacin
ndga
dieter
et
al
recent
respons
shown
suppress
antagonist
bm
puschel
et
al
data
suggest
intrahepat
vasoconstrict
induc
agent
wellknown
activ
macrophag
could
result
secondari
releas
eicosanoid
effect
demonstr
agent
stimul
pge
pgd
product
kupffer
cell
vitro
see
section
pma
shown
induc
product
txa
isol
perfus
rat
liver
tran
thi
et
al
b
furthermor
pge
analog
vasoconstrictor
isol
perfus
rat
liver
pgei
pgd
pgi
significantli
affect
intrahepat
vascular
resist
basal
condit
altin
bygrav
b
haussing
et
al
iwai
et
al
meren
et
al
cysteinyl
leukotrien
ltd
also
potent
vasoconstrict
properti
lte
ltb
inact
iwai
jungermann
iwai
et
al
mediat
studi
appear
potent
evid
respons
eicosanoid
involv
intracellular
ca
mobil
respons
prostaglandin
characterist
consist
brief
transient
mobil
intracellular
ca
haussing
et
al
resembl
obtain
adrenerg
agonist
sympathet
stimul
haussing
et
al
respons
thromboxan
leukotrien
consist
slow
prolong
mobil
intracellular
ca
haussing
et
al
haussing
conclus
find
indic
eicosanoid
produc
sinusoid
cell
play
import
role
regul
hepat
microcircul
concept
could
major
implic
inflammatori
condit
character
increas
product
eicosanoid
lipid
mediat
discuss
later
analog
suggest
vasoconstrict
induc
adrenerg
agonist
could
also
depend
secondari
releas
autacoid
mendlov
et
al
shown
isol
perfus
rat
liver
vasoconstrict
induc
epinephrin
presenc
propranolol
inhibit
ndga
bpb
indomethacin
inact
subsequ
dieter
colleagu
dieter
et
al
report
ndga
bpb
indomethacin
modifi
respons
phenylephrin
iwai
jungermann
found
bpb
weak
inhibitori
effect
vasoconstrict
induc
tm
norepinephrin
bpb
indomethacin
ineffect
reason
discrep
unclear
could
relat
differ
experiment
condit
howev
overal
data
suggest
respons
adrenerg
agonist
mediat
eicosanoid
situat
differ
sympathet
activ
effect
indomethacin
bpb
significantli
inhibit
vasoconstrict
induc
sympathet
stimul
wherea
ndga
inact
iwai
jungermann
suggest
effect
sympathet
stimul
could
mediat
least
part
prostaglandin
andor
thromboxan
releas
secondarili
sinusoid
cell
hypothesi
recent
support
find
sympathet
stimul
elicit
releas
liver
tran
thi
et
al
atp
store
high
concentr
associ
norepinephrin
vesicl
varicos
termin
sympathet
fiber
burnstock
atp
liber
along
norepinephrin
exocytosi
sympathet
nerv
stimul
therefor
suggest
respons
sympathet
stimul
could
mediat
modul
atp
burnstock
atp
also
releas
platelet
influenc
varieti
mediat
sever
produc
inflamm
atp
induc
vasoconstrict
isol
perfus
rat
liver
buxton
et
al
evid
indic
respons
atp
mediat
via
purinerg
receptor
present
smooth
muscl
involv
intracellular
ca
pool
ident
mobil
norepinephrin
prostaglandin
ize
hormon
haussing
et
al
haussing
howev
atpinduc
vasoconstrict
inhibit
bpb
indomethacin
txa
inhibitor
bm
ndga
suggest
effect
atp
hepat
microcircul
could
mediat
least
part
eicosanoid
releas
sinusoid
cell
utp
potent
hepat
vasoconstrictor
atp
haussing
et
al
interestingli
shown
respons
utp
mediat
pyriminiderg
receptor
differ
receptor
haussing
von
kugelgen
et
al
furthermor
effect
utp
ca
flux
differ
atp
similar
observ
cysteinylleukotrien
analog
haussing
et
al
addit
utpinduc
vasoconstrict
inhibit
indomethacin
bm
lastli
atp
utp
elicit
releas
isol
perfus
rat
liver
haussing
et
al
tranthi
et
al
find
suggest
effect
atp
utp
hepat
microcircul
mediat
part
directli
via
specif
receptor
smooth
muscl
partli
eicosanoid
liber
sinusoid
cell
locat
portal
resist
basal
condit
influenc
vasoact
agonist
unknown
import
emphas
site
resist
may
differ
basal
condit
stimul
furthermor
locat
may
chang
accord
stimul
agent
use
microscop
method
rat
reilli
et
al
reilli
et
al
demonstr
compon
microvasculatur
includ
sinusoid
central
venul
abl
constrict
respons
agonist
stimul
howev
direct
measur
pressur
microcircul
basal
condit
indic
rat
resist
locat
portal
venul
ie
presinusoid
nakata
et
al
increas
sinusoid
volum
retrograd
compar
anterograd
perfus
rat
liver
also
support
hypothesi
maximum
resist
perfus
flow
locat
presinusoid
level
bass
et
al
dog
cat
recent
studi
suggest
basal
condit
major
resist
site
postsinusoid
hepat
vein
lautt
et
al
legar
lautt
howev
adrenerg
stimul
presinusoid
compon
observ
lautt
liegar
anoth
import
function
liver
circul
role
blood
reservoir
subject
review
extens
discuss
briefli
see
bennett
roth
donald
roth
roth
splanchnic
vascular
bed
contain
circul
blood
volum
therefor
major
blood
reservoir
dog
cat
spleen
import
compon
human
intestin
liver
play
major
role
greenway
hepat
blood
volum
measur
mean
plethysmographi
greenway
volumepressur
curv
complianc
intrahepat
circul
estim
roth
roth
hepat
blood
volum
estim
rang
mlg
liver
ie
approxim
circul
blood
volum
greenway
hepat
vascular
bed
highli
compliant
shown
steep
linear
volumepressur
relationship
hepat
blood
expel
system
circul
sympathet
nerv
stimul
repres
major
reflex
mechan
compens
hypovolemia
maintain
cardiovascular
homeostasi
hepat
blood
mobil
hepat
vascular
bed
passiv
elast
phenomenon
due
decreas
portal
pressur
andor
portal
flow
result
activ
venoconstrict
occur
via
chang
unstress
volum
ie
volum
zeroflow
pressur
complianc
system
slope
pressurevolum
curv
greenway
et
al
greenway
et
al
greenway
gener
agre
vasoact
mediat
control
transvascular
exchang
fluid
solut
regul
number
open
capillari
b
modifi
permeabilitysurfac
product
ps
individu
capillari
c
chang
capillari
hydrostat
pressur
crone
granger
barrowman
contract
portal
venul
andor
presinusoid
sphincter
andor
sinusoid
vasoact
mediat
reduc
number
perfus
sinusoid
consequ
number
function
hepatocyt
import
emphas
vasoact
mediat
could
modifi
number
perfus
sinusoid
without
chang
critic
close
pressur
chang
liver
blood
flow
accordingli
reduct
liver
blood
flow
could
lead
derecruit
sinusoid
howev
state
previous
clear
phenomenon
occur
normal
condit
physiolog
rang
liver
blood
flow
valu
vasoact
mediat
could
also
contract
sinusoid
without
chang
number
perfus
channel
howev
unlik
reduct
surfac
sinusoid
would
significantli
affect
exchang
across
endotheli
barrier
inasmuch
sinusoid
perfor
larg
fenestr
show
signific
resist
dispers
howev
possibl
mark
contract
endotheli
fenestra
could
restrict
movement
macromolecul
extrem
situat
fenestra
complet
close
dispers
molecul
space
diss
would
chang
flowlimit
diffusionlimit
condit
schafer
andreoli
chang
sinusoid
hydrostat
pressur
unlik
significantli
affect
exchang
across
sinusoid
sinc
permeabl
infinit
high
sinusoid
pressur
ident
interstiti
pressur
chang
hydrostat
pressur
would
transmit
surfac
hepatocyt
would
directli
affect
lymphat
flow
emphas
effect
vasoact
mediat
capillari
exchang
infer
chang
vascular
resist
exampl
skelet
muscl
norepinephrin
increas
resist
concomitantli
augment
capillari
filtrat
coeffici
extract
harper
et
al
hand
intestin
norepinephrin
increas
resist
wherea
capillari
filtrat
coeffici
oz
extract
decreas
significantli
harper
et
al
richardson
indic
clearli
resist
capillari
exchang
regul
separ
varieti
method
use
studi
effect
sympathet
stimul
andor
adrenerg
agent
exchang
across
sinusoid
method
base
studi
intrahepat
distribut
dye
contrast
medium
shown
sympathet
stimul
norepinephrin
administr
caus
redistribut
flow
restrict
circul
ie
strong
reduct
flow
accompani
possibl
closur
vessel
peripher
vs
central
region
liver
daniel
pritchard
pritchard
daniel
howev
note
method
show
gross
variat
intrahepat
vascular
volum
rule
possibl
contract
vessel
still
perfus
continu
uniform
distribut
label
km
microspher
inject
via
hepat
arteri
portal
vein
cat
dog
condit
suggest
larg
area
exclus
present
greenway
oshiro
howev
remain
possibl
smaller
area
vascular
collaps
undetect
microspher
techniqu
present
transillumin
studi
rat
liver
shown
part
microcircul
contract
influenc
adrenerg
agonist
reilli
et
al
one
studi
closur
sinusoid
seen
koo
et
al
howev
state
previous
studi
limit
surfac
edg
liver
hepat
arteriol
usual
termin
measur
tissu
flow
miniatur
probe
posit
liver
surfac
show
norepinephrin
shift
flow
distribut
curv
left
howev
zeroflow
valu
record
suggest
closur
sinusoid
occur
kessler
et
al
kessler
et
al
capillari
filtrat
coeffici
lp
estim
fluid
filter
across
surfac
liver
accumul
plethysmograph
rais
venou
pressur
greenway
one
studi
cat
lp
significantli
modifi
epinephrin
howev
greenway
shown
sympathet
stimul
decreas
lp
venou
pressur
vari
physiolog
rang
suggest
sympathet
stimul
impair
filtrat
across
sinusoid
elucid
mechan
reduct
vectori
transport
metabol
substrat
elimin
liver
determin
number
permeabl
perfus
sinusoid
therefor
studi
substrat
elimin
provid
inform
constraint
exert
vasoact
agent
liver
microcircul
year
ago
brauer
show
isol
rat
liver
perfus
constant
pressur
infus
epinephrin
result
progress
decreas
blood
flow
evid
increas
colloid
extract
accompani
similar
flow
chang
brought
decreas
perfus
pressur
indic
epinephrin
reduc
elimin
effici
liver
find
interpret
due
decreas
number
perfus
sinusoid
well
reduct
vessel
lumen
sinc
time
attempt
confirm
import
find
boobi
powi
shown
norepinephrin
significantli
decreas
rate
elimin
hexobarbiton
isol
rat
liver
perfus
constant
flow
norepinephrin
modifi
hexobarbiton
metabol
liver
slice
microsom
data
interpret
due
effect
liver
microcircul
recent
examin
subject
detail
studi
effect
norepinephrin
portal
blood
flow
hepat
extract
intrins
clearanc
taurochol
major
bile
acid
rat
ballet
et
al
intrins
clearanc
flowindepend
constant
reflect
maxim
abil
liver
remov
substrat
circul
found
norepinephrin
induc
dosedepend
reduct
portal
blood
flow
concomit
dosedepend
decreas
intrins
taurochol
clearanc
interestingli
effect
norepinephrin
signific
physiolog
rang
concentr
x
data
show
norepinephrin
impair
vectori
transport
taurochol
plasma
bile
find
suggest
reduct
taurochol
transport
could
result
vasoconstrict
hepat
microvasculatur
howev
direct
effect
cellular
transport
rule
recent
akerboom
et
al
shown
ca
ionophor
also
induc
vasoconstrict
signific
reduct
hepat
taurochol
transport
impair
taurochol
transport
correct
part
papaverin
suggest
could
secondari
vasoconstrict
hepat
microvasculatur
recent
use
multipl
indic
dilut
techniqu
studi
effect
vasoact
agent
liver
microcircul
ballet
et
al
techniqu
consist
inject
vascular
extravascular
refer
tracer
portal
vein
togeth
substrat
subject
extract
label
erythrocyt
confin
vascular
space
vascular
refer
plasma
dissolv
label
substanc
gain
access
extravascular
space
space
diss
hepatocyt
fenestra
endotheli
cell
albumin
mw
sucros
mw
diffus
extracellular
space
invers
relat
molecular
weight
water
diffus
cellular
space
produc
major
delay
decreas
magnitud
label
albumin
sucros
water
dilut
curv
recov
outflow
respect
label
erythrocyt
analyz
use
flowlimit
model
goreski
extravascular
volum
calcul
displac
outflow
curv
relat
erythrocyt
peaktim
method
directli
differ
mean
transit
time
transittim
method
latter
method
accur
even
system
reduc
permeabl
long
tracer
recov
outflow
furthermor
dilut
curv
tracer
sequestr
intracellularli
taurochol
possibl
estim
three
unidirect
rate
constant
influx
efflux
excret
bile
use
threecompart
elimin
model
develop
techniqu
use
studi
effect
norepinephrin
isol
rat
liver
perfus
constant
flow
rate
ballet
et
al
norepinephrin
administ
concentr
reach
maxim
stress
cryer
norepinephrin
increas
portal
pressur
decreas
sinusoid
volum
reflect
vasoconstrict
liver
microcircul
spite
modif
interstiti
space
albumin
sucros
modifi
cellular
water
space
slightli
increas
concomitantli
norepinephrin
significantli
reduc
taurochol
extract
influx
rate
constant
k
data
therefor
indic
spite
vasoconstrict
properti
hepat
microcircul
norepinephrin
close
sinusoid
inde
closur
would
reduc
concurr
vascular
extravascular
volum
furthermor
extravascular
volum
calcul
accord
transittim
method
modelindepend
approach
differ
significantli
calcul
accord
peaktim
method
modeldepend
approach
suggest
norepinephrin
creat
diffusion
resist
across
endotheli
cell
thu
norepinephrin
unabl
impair
dispers
albumin
albuminbound
substrat
taurochol
space
diss
reduct
taurochol
extract
consequ
vasoconstrict
specif
effect
norepinephrin
cellular
uptak
taurochol
find
agreement
obtain
vivo
cousineau
et
al
cousineau
et
al
goreski
et
al
administr
norepinephrin
reflex
sympathet
activ
dog
ie
decreas
sinusoid
volum
chang
water
cellular
space
data
concern
interstiti
sucros
space
less
reproduc
possibl
due
chang
liver
blood
flow
howev
data
discrep
reichen
et
al
recent
shown
isol
perfus
rat
liver
norepinephrin
decreas
vascular
extravascular
albumin
sucros
space
although
norepinephrin
administ
supraphysiolog
concentr
multipl
indic
dilut
techniqu
use
recent
studi
effect
paf
liver
microcircul
lapoint
olson
shown
isol
perfus
rat
liver
paf
concentr
significantli
decreas
vascular
sucros
interstiti
urea
cellular
space
suggest
substanti
fraction
hepat
parenchyma
exclud
circul
howev
paf
act
mainli
local
mediat
circul
homron
thu
observ
respons
paf
administ
intravascularli
could
artefactu
irrelev
vivo
situat
summari
evid
sympathet
nervou
activ
andor
circul
norepinephrin
induc
mark
contract
sinusoid
howev
physiolog
condit
constraint
appear
significantli
affect
perfus
hepat
parenchyma
therefor
sympathet
activ
redistribut
blood
liver
vascular
space
system
circul
would
impair
exchang
substrat
plasma
hepatocyt
allow
optim
metabol
respons
liver
stress
patholog
condit
effect
sympathet
stimul
may
differ
conceiv
case
concomit
decreas
liver
blood
flow
sympathet
stimul
could
lead
closur
sinusoid
exclus
signific
portion
hepat
parenchyma
inflammatori
condit
excess
product
vasoact
mediat
leucocyt
migrat
liver
parenchyma
could
modifi
effect
sympathet
stimul
hepat
microcircul
final
cirrhosi
develop
fibrosi
creat
diffusion
barrier
sinusoid
could
markedli
chang
dispers
regimen
molecul
across
endothelium
thu
modifi
hepat
respons
stress
varieti
agent
vasoconstrict
effect
hepat
microcircul
induc
glycogenolysi
isol
perfus
rat
liver
glycogenolysi
induc
administr
norepinephrin
adrenerg
agonist
result
direct
effect
hepatocyt
demonstr
respons
cultur
isol
hepatocyt
addit
mechan
could
contribut
glycogenolysi
tissu
hypoxia
induc
vasoconstrict
effect
anoxia
potent
activ
hepat
glycogenolysi
hem
witton
sharma
et
al
shown
due
stimul
phosphorylas
van
de
broeck
et
al
howev
sodium
nitroprussid
inhibit
vasoconstrict
induc
adrenerg
agonist
sympathet
stimul
significantli
modifi
respons
indic
tissu
hypoxia
contribut
glycogenolysi
induc
adrenerg
agonist
hartmann
et
sever
agent
known
stimul
kupffer
cell
paf
buxton
et
al
buxton
et
al
fisher
et
al
shukla
et
al
phorbol
myrist
acet
garciasainz
hernandezsotomayor
patel
zymosan
dieter
et
al
heataggreg
igg
buxton
et
al
buxton
et
al
steinhelp
olson
complement
fraction
puschel
et
al
stimul
glucos
product
isol
perfus
rat
liver
discuss
previous
agent
concomitantli
induc
vasoconstrict
glycogenolysi
result
direct
effect
hepatocyt
sinc
agent
inact
cultur
isol
hepatocyt
seri
experiment
data
suggest
activ
glycogenolysi
could
result
vasoconstrict
eicosanoid
releas
sinusoid
cell
altin
bygrav
garciasainz
respons
suppress
significantli
reduc
phospholipas
cyclooxygenas
inhibitor
antagonist
dieter
et
al
b
agent
stimul
glycogenolysi
induc
releas
cultur
sinusoid
cell
isol
perfus
rat
liver
c
pge
induc
glycogenolysi
isol
perfus
rat
liver
cultur
hepatocyt
analog
leukotrien
induc
glycogenolysi
isol
perfus
rat
liver
cultur
hepatocyt
altin
bygrav
b
iwai
et
al
evid
endotoxin
casteleijin
et
al
b
c
could
stimul
glucos
product
similar
mechan
glycogenolysi
induc
atp
utp
could
result
direct
effect
hepatocyt
prostaglandin
product
sinusoid
cell
haussing
final
glycogenolysi
elicit
sympathet
stimul
could
mediat
least
part
prostaglandin
iwai
jungermann
summari
find
show
hepat
microvasculatur
longer
consid
passiv
structur
ensur
dispers
molecul
liver
rather
sophist
cellular
network
releas
varieti
mediat
modul
liver
metabol
discuss
later
conceiv
inappropri
product
mediat
occur
inflammatori
condit
could
contribut
impair
liver
function
hagmann
et
al
hagmann
keppler
keppler
et
al
alter
liver
microcircul
sinusoid
cell
occur
mani
patholog
state
chang
architectur
microvasculatur
passiv
affect
hemodynam
properti
well
exchang
process
also
recent
recogn
liver
damag
induc
number
agent
mediat
sinusoid
cell
activ
mechan
section
examin
extent
natur
alter
liver
microvasculatur
cirrhosi
alcohol
liver
diseas
sever
model
acut
liver
injuri
also
discuss
contribut
modif
diseas
process
cirrhosi
final
common
pathway
type
chronic
liver
injuri
defin
widespread
fibrosi
format
regener
nodul
involv
dramat
irrevers
modif
liver
architectur
cirrhosi
mark
modif
liver
microcircul
demonstr
wide
accept
chang
contribut
increas
resist
portal
flow
develop
portal
hypertens
also
evid
microcirculatori
disturb
could
contribut
reduc
function
cirrhot
liver
give
brief
overview
major
alter
hepat
microcircul
report
morpholog
hepat
circul
cirrhosi
studi
mean
radiolog
techniqu
light
microscopi
transmiss
electron
microscopi
recent
corros
castscan
electron
microscopi
method
use
anim
experimentallyinduc
cirrhosi
well
cirrhot
patient
cirrhosi
branch
portal
vein
usual
tortuou
irregular
slightli
decreas
calib
gener
modif
slight
shibayama
nakata
b
portal
venul
present
fibrou
septa
prolifer
around
regen
nodul
particularli
macronodular
cirrhosi
thin
septa
andor
constitut
intrahepat
portohepat
shunt
mainli
micronodular
cirrhosi
thick
septa
hirooka
et
al
mark
prolifer
hepat
arteriol
capillari
also
note
fibrou
septa
around
regen
nodul
extent
prolifer
appear
relat
degre
fibrosi
accordingli
suggest
micronodular
wide
septal
cirrhosi
regen
nodul
perfus
termin
arteriol
capillari
macronodular
thin
septal
cirrhosi
nodul
perfus
arteri
capillari
portal
venul
hirooka
et
al
mark
hyperplasia
peribiliari
vascular
plexu
also
observ
sever
studi
even
absenc
prolifer
bile
neoductul
terada
et
al
arterioport
anastomos
report
significantli
increas
cirrhosi
anastomosi
may
develop
termin
arteriol
capillari
termin
portal
venul
sinuosid
evid
intrahepat
shunt
develop
arteriol
hirooka
et
al
branch
hepat
vein
tortuou
irregular
calib
show
stenos
abnorm
pronounc
portal
vein
structur
alter
also
found
smallest
hepat
venul
appear
compress
surround
nodul
shibayama
nakata
sever
structur
modif
sinusoid
also
report
morphometr
studi
shown
surfac
area
calib
sinusoid
usual
decreas
reichen
et
al
vidin
et
al
mark
increas
collagen
deposit
space
diss
consequ
appear
widen
martinez
hernandez
huet
et
al
varin
huet
reichen
et
al
gross
et
al
howev
degre
perisinusoid
fibrosi
vari
greatli
insid
given
region
parenchyma
stenger
sinusoid
normal
structur
other
show
perisinusoid
fibrosi
signific
structur
modif
final
sinusoid
take
appear
capillari
continu
endothelium
lack
fenestra
support
continu
basement
membran
martinez
hernandez
capillar
sinusoid
usual
found
peripheri
nodul
near
fibrou
septa
stenger
modif
may
also
vari
accord
etiolog
cirrhosi
capillar
sinusoid
appear
mark
human
alcohol
cirrhosi
liver
fibrosi
induc
rabbit
cholesterol
stilbestrol
huet
et
al
contrast
cirrhosi
rat
dog
chronic
bile
duct
ligat
signific
fraction
hepat
sinusoid
may
remain
structur
unalt
huet
et
al
major
consequ
structur
modif
liver
microcircul
cirrhosi
increas
intrahepat
portal
resist
howev
exact
mechan
locat
portal
resist
known
initi
thought
increas
resist
postsinusoid
secondari
compress
hepat
venul
regener
nodul
howev
recent
evid
suggest
locat
mainli
level
sinusoid
conn
groszmann
site
increas
vascular
resist
cirrhot
liver
studi
rat
shibayama
nakata
measur
microvascular
pressur
direct
insert
glass
micropipett
tip
diamet
microvessel
cirrhosi
induc
cholinedefici
diet
month
blood
pressur
portal
vein
termin
portal
venul
diamet
mm
respect
termin
hepat
venul
inferior
vena
cava
slightli
normal
data
suggest
increas
vascular
resist
locat
intrahepat
portal
vein
portal
vein
termin
portal
venul
well
sinusoid
termin
portal
venul
termin
hepat
venul
intrahepat
vein
suggest
caus
increas
portal
resist
stenosi
peripher
branch
portal
vein
caus
increas
sinusoid
resist
thought
narrow
sinusoid
hepatocyt
swollen
mark
accumul
fat
droplet
hypothesi
subsequ
confirm
rat
without
steatosi
effect
found
cholinedefici
cirrhot
rat
fed
ordinari
regimen
month
steatosi
absent
calib
sinusoid
normal
increas
sinusoid
resist
elev
portal
pressur
reduc
markedli
shibayama
nakata
find
recent
confirm
isol
rat
liver
perfus
constant
pressur
cirrhot
rat
steatosi
portal
resist
time
normal
cirrhot
rat
without
steatosi
portal
resist
time
normal
shibayama
nakata
microvascular
pressur
also
measur
cirrhot
rat
shibayama
blood
pressur
portal
vein
termin
portal
venul
termin
hepat
venul
inferior
vena
cava
mm
respect
data
show
increas
vascular
resist
intrahepat
portal
vein
sinusoid
increas
sinusoid
resist
associ
narrow
sinusoid
interpret
author
consequ
enlarg
hepatocyt
reduct
vascular
volum
cirrhot
liver
also
observ
rat
cirrhosi
use
multipl
indic
dilut
curv
techniqu
report
rang
varin
huet
anoth
mechan
contribut
narrow
sinusoid
might
enlarg
space
diss
perisinusoid
fibrosi
effect
work
isol
perfus
cirrhot
rat
liver
found
signific
invers
correl
intrahepat
portal
resist
liver
weight
exist
normal
liver
sinc
cirrhosi
liver
volum
invers
correl
degre
fibrosi
intrahepat
portal
resist
would
appear
correl
fibrosi
discuss
later
find
intrahepat
portal
resist
modul
model
vasoact
agent
suggest
part
increas
resist
could
also
caus
contract
cellular
structur
alcohol
cirrhosi
evid
also
suggest
increas
resist
sinusoid
origin
well
known
hemodynam
studi
alcohol
cirrhot
patient
pressur
measur
hepat
vein
wedg
posit
ident
measur
directli
portal
vein
gener
interpret
indic
main
locat
resist
sinusoid
conn
groszmann
caus
increas
resist
could
decreas
sinusoid
calib
perisinusoid
fibrosi
inde
signific
correl
exist
fibrosi
space
diss
portal
pressur
orrego
et
al
alcohol
liver
diseas
induc
baboon
alcohol
feed
earli
select
fibrosi
around
hepat
venul
observ
nakano
et
al
howev
contribut
lesion
increas
resist
unknown
israel
orrego
propos
hepatocyt
enlarg
main
caus
sinusoid
compress
increas
intrahepat
resist
accord
main
argument
favor
hypothesi
follow
morphometr
studi
show
hepatocyt
size
increas
sinusoid
area
decreas
rat
fed
chronic
alcohol
well
patient
alcohol
cirrhosi
vindin
et
al
b
swell
hepatocyt
perfus
isol
rat
liver
hypoton
medium
associ
signific
increas
intrahepat
resist
colman
et
al
c
patient
alcohol
liver
cirrhosi
signific
invers
correl
one
hand
hepatocyt
size
sinusoid
area
hand
portal
pressur
sinusoid
area
reduc
valu
normal
vindin
et
al
cell
enlarg
hypothesi
challeng
huet
et
al
measur
liver
vascular
extravascular
diffus
space
use
multipl
indic
dilut
curv
techniqu
isol
perfus
liver
rat
chronic
intox
alcohol
found
increas
total
liver
volum
increas
cellular
interstiti
volum
signific
chang
sinusoid
volum
furthermor
intrahepat
portal
resist
perfus
liver
portal
pressur
vivo
mastai
et
al
significantli
modifi
final
administr
alcohol
cirrhot
rat
increas
portal
pressur
measur
vivo
consciou
anim
spite
signific
increas
liver
cell
volum
assess
morphometri
huet
et
al
unpublish
data
indic
cell
enlarg
necessarili
associ
reduct
sinusoid
volum
increas
portal
pressur
conclus
evid
suggest
alcohol
cirrhosi
cirrhosi
cirrhosi
induc
cholinedefici
diet
increas
resist
mainli
due
reduct
sinusoid
calib
volum
howev
disagr
caus
sinusoid
reduct
ie
whether
result
hepatocyt
enlarg
fibrosi
space
diss
import
emphas
site
increas
resist
may
differ
varieti
cirrhosi
patient
biliari
cirrhosi
posthepat
macronodular
cirrhosi
pressur
measur
portal
vein
usual
higher
hepat
vein
wedg
posit
suggest
condit
main
site
resist
presinusoid
conn
groszmann
cirrhosi
main
consequ
increas
intrahepat
vascular
resist
increas
pressur
portal
system
develop
portosystem
shunt
therefor
condit
portal
resist
consist
two
parallel
resist
pathway
ie
intrahepat
resist
resist
high
b
collater
resist
resist
low
spite
latter
low
resist
pathway
total
portal
resist
remain
abnorm
high
sikul
et
al
sikul
groszmann
furthermor
number
studi
found
cirrhosi
splanchnic
blood
flow
ie
flow
enter
portal
system
increas
approxim
shown
varieti
experiment
model
partial
ligatur
portal
vein
blanchet
lebrec
groszman
et
al
lebrec
blanchet
vorobioff
et
al
chemicallyinduc
cirrhosi
fernandezmunoz
et
al
biliari
cirrhosi
bosch
et
al
pressureflow
relationship
portal
system
impair
flow
reduc
normal
valu
portal
pressur
remain
high
kroeger
groszmann
sikul
groszmann
increas
portal
inflow
due
vasodil
arteriol
splanchnic
territori
benoit
et
al
benoit
et
al
howev
vasodil
restrict
splanchnic
territori
also
involv
organ
muscl
lead
reduct
peripher
vascular
resist
system
arteri
pressur
increas
cardiac
output
ie
hyperkinet
syndrom
blanchet
lebrec
vorobioff
et
al
mechan
vasodil
unknown
schrier
caramelo
number
studi
suggest
could
secondari
increas
plasma
concentr
vasodilatori
substanc
benoit
et
al
korthui
et
al
sikul
groszmann
andor
reduct
vascular
respons
vasoconstrictor
bomzon
blendi
chiandussi
et
al
kiel
et
al
laragh
et
al
murray
paller
major
complic
portal
hypertens
bleed
esophag
varic
accompani
develop
portosystem
shunt
risk
bleed
cirrhot
patient
esophag
varic
never
bled
estim
approxim
reach
patient
larg
varic
mortal
rate
complic
burrough
pascal
bleed
like
recur
untreat
patient
mortal
rate
patient
pascal
poynard
chaput
sinc
evid
increas
portal
pressur
play
major
part
develop
ruptur
esophag
varic
garciatsao
et
al
research
direct
find
pharmacolog
agent
lower
portal
pressur
theoret
portal
pressur
reduc
either
decreas
splanchnic
blood
flow
decreas
portal
resist
groszmann
et
al
vasoconstrictor
reduct
splanchnic
blood
flow
obtain
either
decreas
cardiac
output
induc
splanchnic
vasoconstrict
vasopressin
decreas
portal
flow
induc
splanchnic
vasoconstrict
groszmann
atterburi
data
suggest
somatostatin
could
act
similar
mechan
bosch
morgan
groszmann
agent
use
patient
bleed
activ
similar
efficaci
obtain
balloon
tamponad
howev
evid
show
conclus
drug
significantli
influenc
surviv
lebrec
cowork
franc
show
propranolol
dose
decreas
heart
rate
significantli
reduc
risk
rebleed
cirrhot
patient
good
overal
condit
studi
landmark
therapi
portal
hypertens
hitherto
consid
inaccess
medic
therapi
mechan
action
propranolol
still
unknown
number
clue
obtain
experiment
studi
bosch
groszmann
atterburi
propranolol
shown
reduc
portal
pressur
antagonist
cardiac
receptor
decreas
cardiac
output
antagonist
splanchnic
receptor
induc
vasoconstrict
via
adrenerg
receptor
unoppos
flzvasodilatori
receptor
kroeger
groszmann
b
mechan
decreas
portal
flow
consequ
portal
pressur
far
seven
control
trial
studi
effect
betablock
risk
rebleed
cirrhot
patient
lebrec
hadengu
howev
although
reduc
four
studi
three
significantli
modifi
surviv
significantli
improv
one
studi
reason
discrep
studi
extens
examin
remain
unclear
lebrec
exampl
alter
fladrenerg
receptor
respons
demonstr
patient
correl
sever
liver
diseas
caujol
et
al
gerb
et
al
gerb
et
al
ramond
et
al
howev
role
factor
therapeut
efficaci
betablock
unknown
caujol
et
al
metaanalysi
trial
shown
betablock
decreas
risk
bleed
two
year
placebo
group
treat
group
howev
heterogen
among
group
signific
definit
conclus
drawn
pignon
et
al
contrast
remain
clear
surviv
significantli
modifi
studi
show
efficaci
propranolol
prevent
rebleed
nil
modest
howev
remain
possibl
subgroup
cirrhot
far
unidentifi
could
benefit
treatment
fladrenerg
agent
also
evalu
prophylaxi
varic
bleed
patient
never
bled
five
control
trial
publish
conn
lebrec
hadengu
show
highli
signific
reduct
risk
bleed
gener
admit
group
patient
risk
bleed
reduc
approxim
furthermor
signific
effect
oneyear
surviv
found
metaanalysi
publish
studi
pignon
et
al
conclus
although
efficaci
propranolol
prevent
rebleed
still
disput
gener
accept
drug
benefici
prophylaxi
varic
bleed
high
risk
patient
never
bled
vasodil
altern
approach
reduc
portal
pressur
decreas
intrahepat
vascular
resist
although
gener
accept
vascular
resist
cirrhot
liver
fix
insensit
vasoact
agent
concept
challeng
bhatal
grossman
author
show
isol
perfus
liver
rat
cirrhosi
vasodil
abl
decreas
intrahepat
portal
resist
liver
perfus
constant
pressur
buffer
solut
contain
albumin
sodium
nitroprussid
x
magnesium
sulfat
x
papaverin
cytochalasin
b
decreas
portal
resist
approxim
prostaglandin
e
isoprenalin
reduc
approxim
bhatal
grossman
isol
perfus
normal
rat
liver
agent
unabl
decreas
resist
significantli
magnesium
sulfat
papaverin
reduc
accord
author
seri
argument
suggest
reduct
resist
vasodil
could
secondari
relax
myofibroblast
effect
myofibroblast
shown
occur
around
sinusoid
vessel
embed
fibrou
septa
rudolph
et
al
b
prepar
contain
myofibroblast
maintain
tonic
contract
vitro
c
strip
granul
tissu
relax
vitro
influenc
prostaglandin
ej
papaverin
cytochalasin
b
data
subsequ
provid
reichen
le
studi
effect
calcium
channel
blocker
verapamil
isol
perfus
liver
rat
cirrhosi
liver
perfus
system
flow
pressur
vari
chang
intrahepat
resist
occur
perfus
medium
contain
human
erythrocyt
albumin
verapamil
concentr
rang
ml
x
decreas
resist
liver
approxim
resist
normal
liver
reduc
oxygen
consumpt
cirrhot
liver
increas
significantli
approxim
intrahepat
shunt
estim
recoveri
label
microspher
liver
outflow
significantli
reduc
interestingli
verapamil
significantli
modifi
sinusoid
volum
estim
label
erythrocyt
dilut
curv
suggest
reduct
resist
due
increas
sinusoid
calib
throughout
length
subsequ
studi
effect
chronic
administr
verapamil
rat
cirrhosi
via
drink
water
day
plasma
concentr
verapamil
ngml
x
system
arteri
pressur
significantli
modifi
intrasplen
pressur
provid
estim
portal
pressur
reduc
approxim
sinusoid
volum
measur
isol
perfus
rat
liver
significantli
modifi
find
suggest
chronic
administr
verapamil
abl
decreas
portal
pressur
cirrhot
rat
vivo
howev
mechan
decreas
intrahepat
resist
could
explain
find
eg
decreas
resist
portosystem
collater
decreas
portal
flow
induc
reflex
splanchnic
vasoconstrict
report
led
us
investig
vascular
respons
cirrhot
liver
vasoact
agent
effect
norepinephrin
angiotensin
ii
vasopressin
studi
isol
perfus
liver
cirrhot
rat
vs
normal
liver
liver
perfus
constant
pressur
basal
condit
intrahepat
vascular
resist
higher
normal
liver
norepinephrin
angiotensin
ii
vasopressin
induc
dosedepend
increas
vascular
resist
normal
well
cirrhot
liver
interestingli
found
maxim
effect
emax
normal
cirrhot
liver
differ
significantli
sensit
norepinephrin
even
increas
cirrhot
liver
angiotensin
ii
decreas
vasopressin
significantli
modifi
overal
data
show
resist
cirrhot
liver
could
modul
three
major
circul
vasoact
hormon
suggest
high
plasma
concentr
mediat
demonstr
cirrhosi
could
contribut
increas
intrahepat
vascular
resist
subsequ
studi
effect
seri
vasodil
use
experiment
model
vasodil
studi
adrenerg
antagonist
prazosin
agonist
clonidin
agonist
isoproterenol
calcium
antagonist
verapamil
diltiazero
nifedipin
nitrovasodil
sodium
nitroprussid
nitroglycerin
vasodil
miscellan
pharmacolog
properti
ie
papaverin
pentoxifyllin
diazoxid
basal
condit
isoproterenol
sodium
nitroprussid
nitroglycerin
papaverin
pentoxifyllin
significantli
decreas
resist
howev
maxim
respons
weak
isoproterenol
drug
activ
therapeut
rang
plasma
concentr
prazosin
propranolol
verapamil
diltiazem
nifedipin
diazoxid
ineffect
plasma
concentr
norepinephrin
increas
cirrhot
patient
arroyo
et
al
bernardi
et
al
bichet
et
al
henriksen
et
al
henriksen
et
al
lenz
et
al
nichol
et
al
ringlarsen
et
al
tagejensen
willet
et
al
discuss
previous
norepinephrin
significantli
increas
intrahepat
resist
cirrhot
liver
therefor
examin
effect
vasodil
induct
vasoconstrict
norepinephrin
prazosin
papaverin
pentoxifyllin
significantli
reduc
vasoconstrict
induc
norepinephrin
significantli
modifi
clonidin
isoproterenol
propranolol
lack
effect
clonidin
cirrhot
liver
contrast
inhibitori
effect
normal
liver
suggest
signific
modif
adrenerg
activ
occur
develop
cirrhosi
lack
respons
calcium
antagonist
discrep
result
obtain
reichen
le
could
relat
differ
experiment
condit
reichen
studi
perfus
flow
pressur
abl
vari
resist
system
pressur
maintain
constant
also
perfus
medium
contain
rat
erythrocyt
reichen
studi
human
erythrocyt
use
sinc
diamet
rat
erythrocyt
much
smaller
human
erythrocyt
verapamil
increas
erythrocyt
deform
would
affect
resist
liver
perfus
humanerythrocyt
rat
erythrocyt
rheolog
factor
could
also
explain
decreas
resist
induc
pentoxifyllin
cirrhot
liver
pentoxifyllin
also
increas
red
blood
cell
deform
howev
low
hematocrit
level
use
studi
chang
viscos
probabl
small
insuffici
account
decreas
resist
conclus
studi
show
spite
fibrosi
vascular
resist
cirrhot
liver
modul
vasoact
agent
howev
reduct
resist
induc
vasodil
small
reduc
presenc
norepinephrin
furthermor
effect
vivo
vasodil
portosystem
collater
splanchnic
circul
could
antagon
potenti
benefici
effect
portal
pressur
blei
effect
isoproterenol
shown
increas
portal
pressur
normal
dog
seaman
greenway
clonidin
decreas
portal
pressur
cirrhot
patient
willet
et
al
suggest
latter
effect
could
result
decreas
intrahepat
portal
resist
willet
et
al
howev
experiment
studi
suggest
may
due
altern
mechan
nitroglycerin
nitrat
also
decreas
portal
pressur
cirrhot
patient
howev
experiment
studi
demonstr
due
reduct
splanchnic
flow
portal
collater
resist
blei
gottstein
final
hemodynam
studi
cirrhot
patient
shown
verapamil
nifedipin
significantli
modifi
portal
pressur
navasa
et
al
role
structur
modif
microcircul
diminish
function
cirrhot
liver
unclear
variou
theori
propos
explain
decreas
clearanc
observ
cirrhosi
sick
cell
hypothesi
state
function
individu
hepatocyt
decreas
capillar
hypothesi
consid
loss
fenestr
endotheli
cell
constitut
continu
basal
layer
beneath
endotheli
cell
decreas
permeabl
sinusoid
diffus
substanc
plasma
huet
et
al
villeneuv
huet
intact
cell
hypothesi
hold
intrahepat
shunt
account
reduc
number
normal
function
perfus
hepatocyt
wood
et
al
differ
approach
use
discrimin
model
possibl
compar
observ
valu
differ
pharmacokinet
paramet
condit
vari
flow
vari
protein
bind
valu
predict
model
exampl
lack
increas
hepat
extract
propranolol
flow
reduc
interpret
indic
intravascular
shunt
present
sinc
case
uniform
reduct
enzym
activ
reduct
flow
increas
extract
wood
et
al
similarli
reduct
hepat
blood
flow
induc
lysinevasopressin
cirrhot
patient
accompani
decreas
intrins
clearanc
indocyanin
green
barbar
et
al
reduct
consist
increas
intrahepat
shunt
flow
decreas
substanc
bound
protein
plasma
anoth
experiment
approach
studi
influenc
vari
unbound
protein
fraction
hepat
elimin
paramet
accord
intact
cell
model
highli
extract
drug
maintain
clearanc
regimen
spite
decreas
extract
extract
slightli
affect
variat
unbound
fraction
due
liver
region
normal
function
hepatocyt
contrast
sick
cell
model
highli
extract
substanc
would
show
modifi
clearanc
regimen
sinc
hepatocyt
suppos
low
extract
condit
extract
low
vari
close
unbound
fraction
capillar
model
substrat
whose
diffus
across
sinusoid
barrier
impair
behav
similarli
ie
extract
reduc
highli
depend
upon
fraction
unbound
protein
isol
perfus
liver
rat
cirrhosi
found
extract
taurochol
substrat
bound
albumin
decreas
strongli
influenc
unbound
fraction
data
consist
either
sick
cell
capillar
model
petit
ballet
unpublish
data
direct
evid
sick
cell
hypothesi
provid
studi
function
hepatocyt
isol
cirrhot
liver
shown
vitro
metabol
propranolol
impair
accompani
reduct
cytochrom
content
villeneuv
et
al
recent
reduc
cellular
uptak
taurochol
ouabain
togeth
reduc
oxygen
consumpt
demonstr
reichen
et
al
howev
must
point
vitro
numer
artifact
experiment
constraint
may
limit
mean
data
exampl
low
yield
dissoci
procedur
may
induc
sampl
artifact
favor
intact
cell
hypothesi
reichen
et
al
found
reduc
aminopyrin
ndemethyl
assess
aminopyrin
breath
test
rat
cirrhosi
correl
liver
cell
volum
microsomai
aminopyrin
ndemethylas
cytochrom
activ
express
per
unit
hepatocyt
volum
maintain
indic
function
individu
cell
remain
unalt
galactos
elimin
capaccircul
iti
also
found
correl
liver
cell
volum
biliari
cirrhosi
rat
gross
et
al
multipleind
dilut
techniqu
use
huet
goreski
montreal
studi
influenc
microcriculatori
alter
exchang
process
cirrhosi
huet
et
al
varin
huet
state
previous
hepat
vascular
volum
estim
diffus
space
label
red
blood
cell
significantli
reduc
major
find
extravascular
diffus
space
albumin
decreas
proport
degre
fibrosi
space
diss
indic
fibrosi
abl
restrict
extravascular
diffus
albumin
fig
least
cirrhot
patient
albumin
diffus
space
even
superimpos
red
blood
cell
thu
provid
direct
demonstr
capillar
sinusoid
fig
huet
et
al
contrast
cirrhosi
rat
capillar
pattern
uncommon
studi
varin
huet
present
cirrhot
liver
studi
reichen
le
reichen
et
al
discrep
probabl
explain
differ
sever
liver
fibrosi
obtain
administr
cirrhot
patient
hepat
extract
icg
dye
highli
proteinbound
decreas
strongli
correl
diffus
space
albumin
huet
et
al
suggest
restrict
diffus
albumin
across
endotheli
barrier
affect
uptak
proteinbound
dye
normal
liver
entri
ofmtc
albumin
alb
space
diss
produc
major
delay
decreas
magnitud
albumin
curv
respect
cr
red
blood
cell
sj
cr
rbc
cirrhot
liver
capillar
limit
diffus
albumin
space
diss
alb
curv
slightli
delay
relat
correspond
rbc
curv
huet
et
al
reprint
permiss
author
copyright
holder
w
b
saunder
philadelphia
modif
diffus
space
sucros
water
difficult
analyz
sinc
least
case
diffus
extravascular
space
appear
flowlimit
indic
diffusion
barrier
level
sinusoid
huet
et
al
cirrhot
patient
well
cirrhot
dog
chronic
bile
duct
ligat
label
erythrocyt
water
lidocain
appear
earli
peak
relat
bulg
erythrocyt
upslop
curv
superimpos
pm
microspher
huet
et
al
earli
peak
interpret
repres
predominantli
throughput
materi
come
vascular
shunt
poorli
permeabl
small
molecul
diffus
freeli
across
membran
lidocain
water
cirrhosi
lidocain
outflow
pattern
form
dilut
curv
slightli
delay
relat
label
red
blood
cell
varin
huet
pattern
differ
systemat
observ
noncirrhot
rat
unchang
lidocain
emerg
substanti
later
trace
amount
contrast
rang
microspher
recov
outflow
find
consist
develop
small
p
intrahepat
shunt
studi
intrahepat
shunt
measur
passag
microspher
higher
highli
variabl
rang
reichen
le
reichen
et
al
discrep
may
relat
differ
sever
cirrhosi
produc
rat
use
cci
hepat
fibrosi
induc
rabbit
cholesterolsupplemnt
diet
stilbestrol
twice
weekli
sc
week
mastai
et
al
b
albumin
diffus
space
markedli
decreas
contrast
water
diffus
space
lidocain
outflow
curv
unchang
recoveri
microspher
less
data
suggest
model
extens
fibrosi
sinusoid
restrict
diffus
albumin
affect
diffus
water
lidocain
ie
intrahepat
shunt
occur
interestingli
found
taurochol
extract
much
strongli
decreas
propranolol
extract
suggest
capillar
select
impair
diffus
hydrophil
proteinbound
substanc
taurochol
opposit
lipophil
drug
propranolol
mastai
et
al
conclus
data
obtain
multipleind
dilut
techniqu
suggest
differ
kind
microcircul
alter
cirrhosi
ie
reduct
vascular
space
b
reduct
extravascular
diffus
space
albumin
pattern
consist
sinusoid
capillar
fibrosi
space
diss
extens
c
develop
larg
small
intrahepat
shunt
consequ
alter
hepat
elimin
unclear
data
suggest
sinusoid
capillar
could
affect
uptak
proteinbound
hydrophil
substrat
icg
taurochol
without
significantli
impair
transport
lipophil
molecul
propranolol
lidocain
intrahepat
shunt
may
major
determin
decreas
extract
lidocain
final
decreas
extract
propranolol
probabl
consequ
reduc
metabol
cellular
activ
intrahepat
shunt
therefor
clear
cirrhosi
multipl
factor
sick
cell
b
intrahepat
shunt
c
decreas
cellular
mass
anatom
barrier
contribut
reduc
liver
function
howev
rel
contribut
factor
may
vari
accord
durat
diseas
superimpos
event
final
main
interest
studi
identifi
factor
could
target
therapeut
intervent
view
possibl
pharmacolog
modul
hepat
microcircul
cirrhosi
obviou
microcirculatori
factor
major
interest
role
microcirculatori
disturb
impair
function
cirrhot
liver
examin
reichen
le
studi
effect
verapamil
x
calcium
channel
blocker
vascular
extravascular
diffus
space
liver
function
isol
perfus
liver
rat
cirrhosi
found
verapamil
affect
hepat
vascular
space
significantli
increas
albumin
extravascular
space
associ
reduct
intrahepat
shunt
concomitantli
signific
improv
oxygen
consumpt
antipyrin
clearanc
propranolol
clearanc
observ
suggest
verapamil
could
relax
endotheli
cell
lead
redistribut
flow
sinusoid
select
wellmaintain
exchang
characterist
find
subsequ
confirm
cirrhot
rat
vivo
oral
administr
verapamil
x
day
signific
improv
hepat
microsom
function
assess
aminopyrin
caffein
breathtest
observ
data
suggest
improv
liver
function
could
result
effect
verapamil
liver
microcircul
mechan
chronic
alcohol
induc
cirrhosi
still
controversi
gener
agreement
cirrhosi
preced
alcohol
hepat
lesion
character
hcpatocyt
necrosi
conjunct
inflammatori
cell
infiltr
predominantli
compos
neutrophil
pericellular
fibrosi
popper
necrosi
alcohol
hepat
occur
characterist
hepat
acinu
zone
centrilobular
area
still
understand
alcohol
caus
liver
damag
unlik
diseas
result
singl
factor
two
interact
mechan
appear
play
predomin
role
acetaldehydeinduc
damag
b
hypox
necrosi
gener
agre
liver
injuri
induc
ethanol
result
product
acetaldehyd
naddepend
alcohol
dehydrogenas
low
blood
ethanol
level
kin
mm
cytochrom
isozym
microsom
ethanol
oxid
system
high
ethanol
level
k
mm
lieber
latter
pathway
predomin
longterm
use
alcohol
shown
associ
mark
prolifer
hepat
microsom
membran
increas
activ
microsom
ethanol
oxid
system
elimin
rate
ethanol
cytochrom
system
requir
nadph
oxygen
acetaldehyd
electrophil
speci
react
nucleophil
site
molecul
number
studi
demonstr
acetaldehyd
bind
vitro
number
macromolecul
cystein
albumin
membran
protein
hemoglobin
lipid
nucleic
acid
lauterburg
bilzer
lieber
furthermor
acetaldehyd
adduct
protein
demonstr
alcohol
patient
clear
howev
interact
lead
cell
necrosi
propos
acetaldehydemedi
cell
death
might
immunolog
compon
immun
cytotox
respons
could
direct
toward
cellular
protein
alter
acetaldehyd
acetaldehyd
could
damag
either
intracellular
protein
subsequ
transport
cell
surfac
plasma
membran
protein
lauterburg
bilzer
state
previous
characterist
featur
alcohol
liver
injuri
predomin
lesion
centrilobular
region
hepat
acinu
sever
factor
could
account
pattern
lieber
low
oxygen
pressur
normal
prevail
perivascular
zone
may
exagger
oxidationreduct
shift
produc
ethanol
result
variou
deleteri
metabol
effect
b
higher
level
alcoholmetabol
enzym
perivenular
zone
could
produc
higher
concentr
acetaldehyd
region
account
centrilobular
locat
lesion
also
suggest
hepatocellular
necrosi
could
result
hypoxia
accord
hypothesi
centrilobular
hypoxia
would
occur
consequ
imbal
increas
oxygen
demand
inadequ
oxygen
deliveri
liver
israel
et
al
israel
orrego
thurman
et
al
inde
demonstr
acut
chronic
ethanol
administr
increas
rate
oxygen
uptak
liver
mechan
increas
oxygen
demand
fulli
elucid
propos
increas
avail
nadh
mitochondri
nadh
oxid
increas
oxid
phosphoryl
increas
oxygen
consumpt
could
also
result
increas
activ
microsom
ethanoloxid
system
direct
requir
oxygen
altern
increas
oxygen
uptak
could
caus
releas
catecholamin
sinc
epinephrin
mimick
increas
observ
ethanol
b
increas
uptak
block
fladrenerg
agent
c
chronic
alcohol
associ
sympathet
hyperact
particularli
ethanol
withdraw
final
thyroid
hormon
function
appear
permiss
effect
occur
level
unchang
acut
chronic
ethanol
administr
thyroidectomi
administr
antithyroid
drug
propylthiouracil
ptu
suppress
abolish
ethanolinduc
hypermetabol
state
increas
consumpt
induc
ethanol
administr
associ
steeper
oxygen
gradient
liver
lobul
demonstr
thurman
perfus
liver
ethanoltr
rat
measur
nadh
fluoresc
tissu
periport
periven
region
microlight
guid
miniatur
oxygen
electrod
increas
oxygen
gradient
along
sinusoid
would
lead
centrilobular
necrosi
condit
reduc
oxygen
avail
support
postul
israel
et
al
shown
brief
exposur
hypoxia
produc
centrilobular
necrosi
ethanoltr
rat
control
pretreat
rat
propylthiouracil
significantli
reduc
tissu
damag
hand
shown
ethanol
increas
hepat
blood
flow
shown
attribut
vasodil
splanchnic
territori
interpret
compensatori
mechan
could
play
import
role
protect
liver
hypox
necrosi
carmichael
et
al
mckaigney
et
al
accordingli
ethanolf
rat
minim
liver
injuri
enhanc
hepat
oxygen
consumpt
adequ
compens
concomit
increas
hepat
oxygen
deliveri
bredfeldt
et
al
howev
rat
model
alcohol
centrilobular
necrosi
recent
shown
increas
oxygen
deliveri
much
small
compens
mark
increas
oxygen
consumpt
french
et
al
tsukamoto
xi
suggest
centrilobular
necrosi
could
result
enhanc
uncompens
hepat
oxygen
consumpt
conclus
evid
alcoholinduc
liver
necrosi
could
due
anox
injuri
centrilobular
hepatocyt
result
imbal
increas
oxygen
consumpt
reduc
oxygen
deliveri
liver
theoret
drug
decreas
oxygen
demand
andor
increas
oxygen
deliveri
liver
thu
benefici
state
previous
propylthiouracil
decreas
oxygen
uptak
liver
two
shortterm
studi
yield
conflict
result
orrego
et
al
israel
et
al
recent
longterm
studi
report
lower
mortal
patient
alcohol
liver
diseas
tempt
specul
benefici
effect
propranolol
liver
cirrhosi
could
relat
part
inhibitori
effect
increas
hepat
oxygen
uptak
due
ethanol
drug
shown
effect
prevent
reduc
hypox
liver
injuri
could
also
benefici
alcohol
liver
diseas
final
drug
increas
liver
blood
flow
oxygen
deliveri
ie
vasodil
test
liver
highli
sensit
ischemia
circulatori
shock
rise
serum
transaminas
sometim
accompani
signific
increas
serum
bilirubin
frequent
observ
lefkowitch
mendez
histolog
studi
show
sinusoid
dilat
variabl
degre
congest
hemorrhag
togeth
centrilobular
necrosi
lefkowitch
mendez
experiment
isol
perfus
liver
rat
fast
hr
hypoxia
induc
decreas
portal
flow
min
stop
flow
min
follow
reperfus
induc
damag
pericentr
region
liver
lobul
bradford
et
al
sequenc
chang
cell
structur
extens
studi
lemast
thurman
lemast
et
al
lemast
et
al
first
lesion
occur
bleb
develop
exclus
sinusoid
surfac
hepatocyt
project
fenestr
endothelium
sinusoid
subsequ
bleb
detach
cell
releas
microcircul
concomit
releas
cytosol
enzym
lactat
dehydrogenas
effluent
final
break
appear
plasma
membran
lead
membran
hyperperm
cellular
stain
dye
normal
exclud
trypan
blue
propidium
iodid
event
indic
abrupt
transit
revers
irrevers
injuri
sensit
liver
ischemia
also
account
imposs
extend
preserv
time
liver
allograft
cold
storag
beyond
standard
preserv
solut
belzer
southard
mechan
cell
necrosi
mechan
hypoxiaor
ischemiainduc
hepatocyt
necrosi
poorli
understood
bonventr
leaf
et
al
gener
assum
primari
target
injuri
hepatocyt
propos
cell
death
could
occur
result
gener
situ
oxygenderiv
free
radic
bonventr
mccord
park
granger
granger
accord
hypothesi
ischemia
trigger
convers
xanthin
dehydrogenas
oxygen
radic
produc
xanthin
oxidas
mckelvey
et
al
concomitantli
cellular
atp
catabol
hypoxia
period
hypoxanthin
reperfus
reoxygen
molecular
oxygen
react
hypoxanthin
xanthin
oxidas
produc
highli
cytotox
reactiv
metabolit
superoxid
hydrogen
peroxid
hydroxyl
radic
oh
mainli
base
observ
allopurinol
xanthin
oxidas
inhibitor
prevent
ischemiaor
hypoxiainduc
liver
injuri
mccord
also
propos
hepatocyt
death
could
result
massiv
cellular
influx
calcium
accord
hypothesi
result
increas
cytosol
calcium
could
activ
sever
enzym
phospholipas
proteas
endonucleas
activ
enzym
could
secondarili
induc
cell
kill
mechan
extens
review
bonventr
orreniu
bellomo
pound
rosen
accordingli
shown
sever
blocker
protect
effect
liver
ischemia
hypoxia
lefer
stahl
lefer
papanicola
peck
lefer
thurman
et
al
thurman
et
al
well
establish
addit
lesion
parenchym
celt
ischemia
hypoxia
induc
alter
microcircul
shown
number
experiment
model
ischemia
increas
vascular
resist
capillari
permeabl
korthui
et
al
differ
degre
endotheli
cell
damag
demonstr
burton
et
al
cell
swell
break
cytoplasm
process
extend
cell
bodi
bulg
vascular
space
final
detach
increas
resist
attribut
sever
factor
ie
braunwald
kloner
occlus
vessel
leucocyt
plug
result
adhes
endothelium
b
swell
endotheli
cell
c
pericapillari
edema
increas
capillari
permeabl
attribut
disrupt
widen
intercellular
junction
either
passiv
due
cytoskelet
alter
activ
cell
contract
induc
vasoact
mediat
svensjo
grega
howev
also
report
increas
capillari
permeabl
observ
without
structur
modif
interendotheli
junction
rasio
et
al
endotheli
cell
injuri
attribut
product
oxygenderiv
free
radic
xanthin
oxidas
present
endotheli
cell
burton
et
al
ratych
et
al
rosen
freeman
zweier
et
al
endotheli
cell
could
also
damag
join
action
oxygenderiv
free
radic
proteas
secret
neutrophil
migrat
interstitium
fig
ratych
et
al
hernandez
et
al
granger
importantli
shown
differ
model
alter
microvasculatur
occur
earli
appear
preced
lesion
epitheli
cell
burton
et
al
braunwald
kloner
suggest
parenchym
cell
injuri
could
consequ
alter
microcircul
experiment
evid
also
suggest
ischemia
hypoxia
induc
earli
select
damag
liver
microcircul
could
significantli
contribut
parenchym
cell
lesion
lesion
endotheli
cell
demonstr
rat
liver
store
hr
naci
solut
contain
mm
mckeown
et
al
hr
endotheli
cell
swollen
number
size
fenestr
increas
hr
larg
disrupt
continu
endothelium
seen
recent
shown
ballet
unpublish
data
use
isol
perfus
liver
fast
rat
l
hr
ischemia
follow
onset
ischemia
xanthin
dehydrogenas
xd
convert
xanthin
oxidas
xo
within
endotheli
cell
xanthin
oxidas
catalyz
superoxid
gener
within
endotheli
cell
molecular
oxygen
reintroduc
reperfus
endothelialcellgener
superoxid
produc
direct
cellular
injuri
independ
element
neutrophil
pmn
attract
area
secondarili
either
chemotact
properti
superoxid
andor
injur
endotheli
cell
neutrophil
may
undergo
activ
serv
import
secondari
amplifi
system
result
cellular
injuri
endotheli
parenchym
cell
ratych
et
al
reprint
permiss
author
copyright
holder
cu
mosbi
co
st
loui
min
reperfus
induc
mediolobular
parenchym
cell
death
assess
trypan
blue
stain
agreement
recent
studi
marotto
et
al
signific
endotheli
cell
injuri
also
observ
interestingli
restrict
midzon
region
involv
whole
lobul
abnorm
accompani
mark
alter
liver
microcircul
indic
reduct
liver
blood
flow
increas
intrahepat
vascular
resist
well
heterogen
stain
liver
trypan
blue
perfus
ballet
unpublish
data
recent
komatsu
et
al
koo
et
al
use
viva
model
ischemiareperfus
rat
viva
microscop
techniqu
shown
reperfus
leucocyt
veloc
significantli
decreas
sinusoid
adhes
leucocyt
endothelium
cessat
blood
flow
mani
sinusoid
abnorm
prevent
part
administr
superoxid
dimutas
thu
confirm
role
superoxid
anion
alter
protect
effect
calcium
antagonist
variou
model
hypox
ischem
liver
injuri
interpret
consequ
direct
effect
hepatocyt
thurman
et
al
howev
evid
voltagedepend
calcium
channel
bind
dihydropyrimidin
exist
hepatocty
mauger
claret
contrast
channel
present
smooth
muscl
cell
endotheli
cell
macrophag
therefor
hepatoprotect
properti
agent
could
relat
effect
microcircul
andor
sinusoid
cell
similar
mechan
could
also
account
protect
effect
prostaglandin
alvareslopez
et
al
araki
lefer
mora
et
al
sikugara
et
al
conclus
sever
line
evid
suggest
addit
necrosi
parenchym
cell
liver
ischemiahypoxia
induc
mark
abnorm
liver
microcircul
togeth
lesion
endotheli
cell
howev
phenomena
occur
simultan
must
emphas
data
present
insuffici
establish
causeeffect
relationship
microcirculatori
disturb
also
demonstr
preserv
liver
hypertherm
ischemia
otto
et
al
observ
effect
graft
cool
minipig
liver
ultrastructur
administr
ringer
initi
flush
donor
liver
induc
complet
desquam
endothelium
togeth
minor
hepatocyt
lesion
contrast
flush
ringer
minor
alter
occur
preserv
eurocollin
protein
solut
hr
extent
damag
similar
howev
transplant
reperfus
liver
endotheli
damag
pronounc
parenchym
necrosi
appar
author
suggest
liver
parenchym
cell
damag
mainli
reflow
consequ
microcirculatori
disturb
myagkaya
et
al
also
shown
flush
rat
liver
eurocollin
preserv
small
piec
perfus
liver
eurocollin
select
lesion
endotheli
cell
occur
hr
interrupt
continu
endotheli
line
regularli
observ
nuclear
chromatin
cell
show
pronounc
clump
hr
necrosi
desquam
endotheli
cell
seen
data
suggest
hepatocyt
injuri
could
relat
endotheli
cell
damag
iu
et
al
shown
hr
preserv
salin
solut
contain
calcium
rat
liver
graft
nonviabl
mortal
recipi
anim
liver
preserv
condit
perfus
constant
pressur
signific
decreas
flow
observ
compar
control
nonpreserv
liver
ultrastructur
studi
demonstr
necrosi
desquam
endotheli
cell
hepatocyt
lesion
minim
consist
bleb
mild
vacuol
mckeown
et
al
import
emphas
work
ultrastructur
abnorm
present
ischemia
absenc
reperfus
suggest
ischemia
alon
abl
damag
endotheli
cell
durat
preserv
extend
beyond
rat
liver
graft
viabl
surviv
day
recipi
condit
flow
maintain
endotheli
cell
alter
minim
mckeown
et
al
data
clearli
demonstr
sinusoid
damag
microcirculatori
disturb
critic
determin
graft
failur
transplant
find
confin
group
caldwellkenkel
et
al
shown
hr
preserv
eurocollin
follow
reperfus
min
approxim
one
third
sinusoid
cell
nonviz
indic
trypan
blue
uptak
belinski
et
al
durat
reperfus
limit
min
sinusoid
cell
stain
suggest
endotheli
damag
occur
reperfus
preserv
thurman
et
al
subsequ
observ
short
min
preserv
cold
ringer
spotti
uneven
distribut
trypan
blue
occur
liver
transplant
hepatocyt
nonviabl
contrast
untranspl
liver
judg
normal
criteria
uniform
distribut
dye
dye
uptak
alter
microcircul
cell
death
reduc
markedli
liver
perfus
briefli
nitrogensatur
buffer
min
prior
transplant
suggest
oxygenderiv
free
radic
involv
parenchym
injuri
protect
even
greater
perfus
medium
contain
verapamil
calcium
antagonist
state
previous
protect
offer
verapamil
could
relat
effect
microcircul
andor
sinusoid
cell
interestingli
shown
spite
lesion
transplant
anim
abl
surviv
day
import
observ
suggest
extent
cell
damag
modest
andor
factor
necessari
induc
graft
failur
transplant
thurman
et
al
conclus
endotheli
cell
injuri
microcirculatori
abnorm
appear
play
major
role
pathogenesi
liver
failur
prolong
cold
preserv
andor
orthotop
transplant
rat
obsrvat
led
us
investig
effect
two
vasodil
papaverin
methylxanthin
deriv
pentoxifyllin
liver
hemodynam
function
immedi
hr
preserv
et
al
rat
liver
cool
situ
portal
flush
ringerlact
solut
preserv
solut
eurocollin
exciz
store
eurocollin
hr
liver
reperfus
min
constant
pressur
portal
vein
recircul
perfus
organ
system
hr
preserv
liver
hemodynam
function
significantli
modifi
hr
bile
flow
intrins
taurochol
clearanc
significantli
reduc
transaminas
potassium
releas
markedli
increas
histolog
studi
show
mild
centrilobular
necrosi
concomitantli
liver
blood
flow
significantli
reduc
intrahepat
vascular
resist
increas
papaverin
pentoxifyllin
administ
preserv
time
reperfus
significantli
improv
paramet
improv
pronounc
pentoxifyllin
administr
group
show
signific
differ
studi
paramet
vs
control
liver
thu
papaverin
pentoxifyllin
significantli
protect
liver
long
hypotherm
preserv
provid
evid
abnorm
liver
microcircul
major
import
pathogenesi
liver
injuri
hypotherm
storag
et
al
howev
precis
mechan
papaverin
pentoxifyllin
exert
hepatoprotect
effect
experiment
condit
specul
view
increas
intrahepat
resist
hypotherm
storag
vasodilatori
properti
compound
two
mechan
propos
inhibitori
effect
intrahepat
vasoconstrict
portal
venul
andor
sinusoid
sphincter
prevent
closur
sinusoid
b
action
sinusoid
endothelium
possibl
involv
relax
contract
endotheli
cell
intrahepat
vasoconstrict
may
elicit
preserv
high
potassium
concentr
eurocollin
solut
mm
may
persist
reperfus
hill
olson
taylor
et
al
vasoconstrict
portal
venul
sphincter
lead
closur
sinusoid
could
restrict
vascular
extravascular
diffus
preserv
solut
consequ
reduc
number
protect
cell
reperfus
might
also
impair
nutrient
suppli
cell
taurochol
uptak
result
decreas
bile
flow
intrins
taurochol
clearanc
microcirculatori
disturb
also
result
endotheli
cell
injuri
swell
endotheli
cell
may
contribut
increas
vascular
resist
endotheli
cell
contract
could
also
import
mechan
contribut
increas
portal
resist
sinusoid
injuri
sinusoid
endotheli
cell
contain
actin
myosin
contract
influenc
vasoact
agonist
grega
b
grega
et
al
svensjo
grega
reperfus
activ
contract
could
also
induc
massiv
influx
calcium
andor
product
free
radic
endotheli
cell
activ
kupffer
cell
secret
vasoact
mediat
leukotrien
plateletactiv
factor
might
induc
endotheli
cell
contract
would
lead
cell
bulg
protrus
sinusoid
lumen
increas
vascular
resist
facilit
endotheli
cell
separ
detach
influenc
shear
forc
flow
parenchym
cell
injuri
could
occur
secondarili
result
noreflow
phenomenon
worsen
cellular
ischemia
therefor
tempt
specul
papaverin
pentoxifyllin
act
antagon
endotheli
cell
contract
inde
propos
adrenerg
agonist
calcium
antagonist
xanthin
deriv
inhibit
increas
vascular
permeabl
induc
inflammatori
mediat
could
act
relax
mediatorcontract
endotheli
cell
grega
mechan
could
account
protect
offer
two
agent
endotheli
cell
could
damag
free
radic
produc
situ
free
radic
proteolyt
enzym
secret
activ
kupffer
cell
accordingli
inhibit
kupffer
cell
could
prevent
liver
injuri
induc
prolong
preserv
papaverin
pentoxifyllin
potent
inhibitor
cyclic
nucleotid
phosphodiesteras
increas
intracellular
cyclic
amp
agent
increas
cyclic
amp
known
inhibit
secretori
respons
neutrophil
macrophag
shown
pentoxifyllin
inhibit
superoxid
product
human
alveolar
macrophag
vitro
dosedepend
fashion
housset
et
al
find
suggest
inhibit
kupffer
cell
could
explain
benefici
effect
pentoxifyllin
recent
demonstr
preserv
eurocollin
follow
min
reperfus
kupffer
cell
present
morpholog
modif
consist
function
activ
caldwellkenkel
et
al
alter
observ
absenc
reperfus
suggest
cellular
activ
trigger
reperfus
group
also
shown
rat
liver
perfus
hr
preserv
hepat
clearanc
colloid
carbon
increas
twofold
thurman
et
al
indic
cold
preserv
follow
reperfus
activ
kupffer
cell
mechan
could
contribut
endotheli
cell
damag
microcirculatori
disturb
endotoxin
effect
infect
gramneg
bacteria
mediat
endotoxin
endotoxin
lipopolysaccharid
resid
outer
membran
bacteria
consist
polysaccharid
chain
associ
lipid
van
devent
et
al
polysaccharid
region
divid
oantigen
polysaccharid
side
chain
near
nonreduc
end
core
polysaccharid
region
bind
lipid
near
reduc
end
lipid
constant
molecular
structur
thought
mediat
biolog
effect
endotoxin
spite
tremend
concentr
bacteria
gut
littl
evid
physiolog
portal
endotoxemia
occur
van
devent
et
al
contrast
diseas
gut
particularli
larg
bowel
endotoxin
absorb
intestin
wall
reach
liver
van
devent
et
al
liver
specif
sinusoid
cell
respons
uptak
inactiv
endotoxin
nolan
cohen
kupffer
cell
appear
mainli
respons
uptak
mediat
specif
membran
receptor
van
bossuyt
wiss
spite
phagocyt
properti
endotheli
cell
appear
play
role
endotoxin
uptak
liver
least
normal
condit
recent
shown
endotoxin
taken
kuppfer
cell
subsequ
transfer
hepatocyt
excret
bile
endotoxin
activ
kupffer
cell
shown
vitro
endotoxin
induc
releas
kupffer
cell
wherea
basal
condit
major
prostaglandin
secret
kuiper
et
al
decker
et
al
effect
inhibit
dexamethason
dieter
et
al
endotoxin
alon
stimul
superoxid
product
dieter
et
al
increas
superoxid
releas
induc
zymosan
rieder
et
al
affect
secret
lysosom
enzym
recent
shown
endotoxin
select
trigger
tnf
secret
kupffer
cell
respons
inhibit
dexamethason
pge
decker
et
al
clearanc
endotoxin
liver
decreas
signific
amount
may
reach
system
circul
lead
harm
effect
circulatori
shock
intravascular
coagul
metabol
alter
eg
increas
protein
catabol
lipolysi
discrep
hepat
alter
caus
endotoxin
gener
admit
endotoxin
produc
cholestasi
without
evid
parenchym
cell
necrosi
howev
liver
parenchym
injuri
report
vivo
administr
endotoxin
anim
fraker
et
al
vivo
liver
damag
could
result
direct
effect
endotoxin
liver
shock
andor
intravascular
coagul
inde
isol
perfus
rat
liver
hepatocyt
vitro
endotoxin
administr
caus
cytotox
effect
utili
et
al
baboon
mortal
liver
necrosi
induc
inject
e
coli
prevent
administr
c
protein
substanc
particip
endotheli
cell
anticoagul
function
taylor
et
al
furthermor
hepat
necrosi
induc
rat
endotoxin
prevent
thrombin
inhibitor
arai
et
al
find
suggest
activ
coagul
play
role
liver
injuri
invas
liver
parenchyma
neutrophil
could
also
contribut
liver
damag
endotoxin
endotoxin
shown
induc
inflammatori
reaction
mani
organ
major
event
follow
administr
endotoxin
varieti
experiment
model
includ
cybulski
et
al
fig
neutrophil
adhes
endotheli
cell
step
appear
mediat
interleukin
il
tumor
necrosi
factor
tnf
secret
macrophag
b
emigr
neutrophil
endoecoli
thelium
accumul
tissu
interstitium
c
releas
oxygen
radic
proteas
migrat
neutrophil
lead
microvascular
hemorrhag
thrombosi
mechan
recent
explor
liver
schlayer
et
al
shown
endotoxin
induc
neutrophil
adhes
sinusoid
endotheli
cell
vitro
schlayer
et
al
effect
mediat
tnf
tnfc
could
act
directli
activ
neutrophil
andor
indirect
mechan
depend
tnf
bind
endotheli
cell
mccuskey
studi
effect
endotoxin
hepat
microcircul
use
vivo
microscopi
found
endotoxin
trigger
neutrophil
adhes
endotheli
cell
lead
partial
complet
plug
sinusoid
well
reduct
cessat
blood
flow
howev
given
highli
anastomot
natur
sinusoid
network
result
redistribut
flow
adjac
sinusoid
anastomot
sinusoid
eventu
becom
plug
region
liver
parenchyma
may
becom
ischem
effect
endotoxin
liver
hemodynam
unclear
endotoxin
increas
intrahepat
vascular
resist
isol
rat
liver
perfus
recircul
system
gaeta
et
al
nolan
oconnel
utili
et
al
utili
et
al
utili
et
al
singl
pass
system
ballet
unpublish
data
one
studi
vasoconstrict
observ
perfus
solut
contain
whole
blood
mixtur
leucocyt
platelet
plasma
filkin
contrast
respons
obtain
perfus
medium
contain
plasma
kreb
buffer
erythrocyt
leucocyt
filkin
studi
weak
respons
obtain
liver
perfus
simpl
buffer
solut
gaeta
et
al
nolan
oconnel
one
increas
resist
inhibit
hydrocortison
nolan
oconnel
analog
metabol
effect
intact
liver
see
section
take
account
effect
kupffer
cell
vitro
conceiv
effect
endotoxin
liver
microcircul
could
result
releas
eicosanoid
sinusoid
cell
pgd
appear
vasoact
effect
liver
contrast
txa
andor
lt
potent
vasoact
properti
could
mediat
hemodynam
respons
endotoxin
liver
summari
microcirculatori
factor
play
major
role
pathogenesi
endotoxininduc
liver
injuri
adhes
neutrophil
endothelium
could
stop
flow
sinusoid
lead
parenchym
ischemia
migrat
neturophil
endotheli
line
accumul
liver
parenchyma
could
secondarili
induc
endotheli
injuri
therebi
increas
alter
liver
perfus
activ
coagul
mechan
sinusoid
although
endotoxin
per
se
appear
induc
moder
liver
injuri
shown
massiv
necrosi
liver
result
two
condit
ie
suscept
threshold
hepatocyt
lower
pretreat
anim
dgalactosamin
low
noncytotox
dose
number
hepat
macrophag
increas
hepat
necrosi
induc
galactosamin
endotoxin
pretreat
galactosamin
low
noncytotox
dose
dramat
increas
sensit
anim
endotoxin
vivo
galano
et
al
model
hypersensit
induc
galactosamin
consequ
increas
macrophag
activ
result
lower
suscept
threshold
hepatocyt
activ
kupffer
cell
induc
necrosi
associ
galactosamin
indic
cytotox
induc
secret
mediat
specif
trigger
endotoxin
administr
tnf
reproduc
liver
necrosi
mice
pretreat
galactosamin
whether
sensit
n
resist
j
endotoxin
lehmann
et
al
impli
model
effect
endotoxin
vivo
mediat
tnf
resist
endotoxin
result
deficit
tnf
synthesi
macrophag
fraker
et
al
tieg
et
al
also
known
administr
tnf
reproduc
cytotox
effect
endotoxin
respons
tnf
dosedepend
furthermor
plasma
concentr
tnf
significantli
increas
maxim
hr
administr
endotoxin
model
plasma
concentr
reach
level
cytotox
rang
interestingli
tnf
alon
cytotox
shown
model
endotoxin
induc
dramat
accumul
neutrophil
liver
parenchyma
furthermor
shown
fibrin
deposit
often
present
sinusoid
data
suggest
activ
neutrophil
coagul
pathway
contribut
liver
injuri
endotoxin
could
stimul
tnf
secret
kupffer
cell
trigger
endotheli
procoagul
activ
induc
adhes
neutrophil
endotheli
cell
lead
plug
sinusoid
alter
microcircul
migrat
liver
parenchyma
neutrophil
could
induc
hepatocyt
endotheli
cell
necrosi
would
produc
microthrombu
format
microcirculatori
disturb
final
tissu
ischemia
aggrav
parenchym
necrosi
interestingli
shown
model
hepat
necrosi
prevent
allopurinoi
inhibitor
xanthin
oxidas
wendel
et
al
impli
mechan
similar
seen
ischemia
reperfusioninduc
damag
could
occur
prostacylin
analog
iloprost
antagon
liver
injuri
given
simultan
galactosamineendotoxin
wendei
et
al
phospholipas
inhibitor
dexamethason
lipooxigenas
inhibitor
bw
c
nafazatrom
rv
ebselen
lta
biosynthesi
inhibitor
diethylcarbazin
also
prevent
galactosamineendotoxin
hepat
tieg
wendel
suggest
leukotrien
synthesi
involv
mechan
injuri
cytotox
also
decreas
hepat
glutathion
content
decreas
follow
administr
phoron
diethylmal
suggest
glutathionederiv
cysteinyl
leukotrien
may
pathogen
mediat
gamma
glutamyl
transpeptidas
inhibitor
prevent
convers
ltd
significantli
reduc
liver
injuri
furthermor
ltd
receptor
antagonist
fpl
signific
protect
effect
damag
replic
substitut
endotoxin
strongli
support
major
pathogen
mediat
model
ltd
could
induc
transitori
liver
vasoconstrict
lead
ischemia
follow
liver
injuri
time
reperfus
tieg
wendel
accord
hypothesi
protect
effect
analog
iloprost
could
relat
inhibit
vasoconstrict
recent
tieg
et
al
shown
allopurinol
iloprost
dexamethason
bw
c
fpl
ineffect
tnf
substitut
endotoxin
tieg
et
al
indic
agent
could
also
act
inhibit
secret
tnf
andor
antagon
activ
similarli
calcium
channel
blocker
verapamil
nifedipin
significantli
prevent
liver
injuri
model
ineffect
tnf
substitut
endotoxin
indic
agent
could
act
inhibit
secret
tnf
andor
antagon
activ
accord
author
data
suggest
secret
tnf
could
result
gener
oxygenderiv
free
radic
time
reperfus
follow
activ
xanthin
oxidas
ischemia
accord
hypothesi
ischemia
could
result
vasoconstrict
induc
ltda
protect
effect
calcium
channel
blocker
could
relat
inhibit
vasoconstrict
tieg
et
al
howev
mechan
may
involv
discuss
previous
tnf
directli
cytotox
trigger
endotheli
procoagul
activ
adhes
neutrophil
endotheli
cell
secret
oxygenderiv
free
radic
neutrophil
cysteinyl
leukotrien
could
increas
permeabl
sinusoid
facilit
migrat
neutrophil
liver
parenchyma
fordhutchinson
lewi
austen
samuelsson
et
al
corynebacterium
parvum
propionibacterium
acn
follow
endotoxin
endotoxin
trigger
massiv
liver
necrosi
hepat
macrophag
content
increas
prior
inject
corynebacterium
parvum
rat
tanner
et
al
propionibacterium
acn
mice
mizoguchi
et
al
liver
necrosi
significantli
reduc
administr
superoxid
dismutas
arthur
et
al
furthermor
endotoxin
stimul
superoxid
releas
hepat
macrophag
isol
rat
pretreat
c
parvum
arthur
et
al
data
suggest
oxygenderiv
free
radic
secret
hepat
macrophag
influenc
endotoxin
could
induc
liver
injuri
mizoguchi
et
al
shown
hepat
induc
p
acnesendotoxin
mice
pge
analog
decreas
liver
injuri
mortal
significantli
mechan
pge
exert
hepatoprotect
properti
unclear
pgei
inhibit
product
cytotox
mediat
adher
liver
cell
vitro
also
prevent
cytotox
effect
supernat
medium
condit
adher
cell
mizoguchi
et
al
indic
pge
could
inhibit
releas
cytotox
mediat
liver
macrophag
could
also
exert
cytoprotect
effect
hepatocyt
recent
shown
antithrombin
iii
administr
induc
signific
biolog
histolog
improv
model
find
suggest
activ
coagul
play
role
physiopatholog
liver
damag
yamada
et
al
also
evid
sinusoid
cell
microvascular
factor
involv
two
experiment
model
hepat
induc
virus
murin
hepat
viru
mhv
frog
viru
fv
hepat
induc
mhv
mhv
coronaviru
known
exert
direct
cytopath
effect
hepatocyt
vitro
suscept
mice
mhv
induc
focal
parenchym
necrosi
surround
inflammatori
infiltr
extent
necrosi
vari
accord
suscept
strain
accordingli
spectrum
liver
damag
may
rang
fulmin
hepat
lead
death
day
chronic
aggress
hepat
progress
death
month
direct
observ
microcircul
vivo
microscopi
shown
mark
alter
may
occur
mcphee
et
al
importantli
appear
preced
lesion
hepatocyt
earli
find
deposit
fibrin
microthrombi
sinusoid
associ
reduct
sinusoid
flow
format
clump
erythrocyt
dilat
sinusoid
pattern
qualifi
granular
blood
flow
subsequ
avascular
parenchym
area
occur
correspond
necrot
foci
studi
microcircul
corros
castsem
techniqu
confirm
sinusoid
obstruct
earli
hr
inocul
lead
complet
occlus
small
spheric
zone
liver
parenchyma
mcphee
et
al
mean
diamet
lesion
ftm
repres
width
hepatocyt
sinusoid
obstruct
induc
protrus
sinusoid
cell
plug
clump
erythrocyt
andor
platelet
andor
cellular
debri
subsequ
ischem
foci
increas
size
reach
nearconflu
time
death
day
postinfect
importantli
lesion
appear
predomin
periport
region
signific
increas
macrophag
procoagul
activ
correl
degre
parenchym
injuri
model
mcphee
et
al
abecassi
et
al
final
shown
administr
dimethylpg
prevent
stimul
macrophag
procoagul
activ
significantli
reduc
liver
injuri
abecassi
et
al
data
suggest
follow
sequenc
mhv
infect
andor
lesion
endotheli
cell
could
trigger
procoagul
activ
activ
coagul
format
fibrin
microthrombi
sinusoid
impair
microcircul
concomitantli
releas
oxygenderiv
free
radic
kupffer
cell
could
contribut
sinusoid
parenchym
damag
accord
predomin
periport
local
lesion
lesion
sinusoid
could
lead
obstruct
format
foci
ischem
necrosi
liver
parenchyma
howev
also
clear
infect
hepatocyt
mhv
directli
damag
cell
infect
rat
mice
fv
lead
fulmin
hepat
death
less
hr
liver
injuri
predomin
periport
midlobular
region
earli
select
necrosi
endotheli
kupffer
cell
observ
model
lead
destruct
sinusoid
kirn
et
al
lesion
result
infect
sinusoid
cell
viru
parenchym
lesion
occur
secondarili
nuclear
modif
follow
cytoplasm
lesion
lead
hepatocyt
necrosi
sequenc
lesion
suggest
parenchym
lesion
could
secondari
alter
sinusoid
kirn
et
al
data
also
suggest
endotoxin
normal
inactiv
kupffer
cell
endotheli
cell
could
contribut
liver
injuri
endotoxin
administr
aggrav
liver
lesion
inocul
subleth
dose
viru
increas
suscept
anim
endotoxin
b
liver
injuri
significantli
reduc
colectomi
suppress
pool
enter
endotoxin
germfre
anim
administr
polymyxin
b
inactiv
endotoxin
follow
develop
endotoxin
toler
repeat
administr
nonleth
dose
howev
discuss
previous
endotoxin
per
se
cytotox
normal
hepatocyt
inhibit
rna
synthesi
fv
protein
hepatocyt
could
thu
increas
suscept
endotoxin
kirn
et
al
recent
studi
shown
cysteinyl
leukotrien
also
contribut
pathogenesi
hepat
effect
secret
cysteinyl
leukotrien
bile
significantli
increas
reach
level
similar
observ
sever
traumat
injuri
hagmann
et
al
furthermor
inhibit
leukotrien
biosynthesi
lipooxigenas
inhibitor
aa
bw
c
significantli
decreas
liver
injuri
hagmann
et
al
final
import
emphas
endotoxin
potent
stimul
leukotrien
synthesi
secret
varieti
experiment
system
howev
origin
leukotrien
secret
bile
fv
hepat
unknown
state
previous
kupffer
cell
liver
cell
known
produc
signific
amount
leukotrien
hagmann
keppler
accordingli
kupffer
cell
could
produc
leukotrien
earli
infect
fv
destruct
viru
anoth
possibl
leukotrien
releas
polymorphonuclear
cell
andor
monocyt
circul
blood
infiltr
liver
parenchyma
mullan
et
al
mechan
leukotrien
could
trigger
liver
injuri
unclear
leukotrien
could
impair
microcircul
effect
observ
liver
microcircul
vivo
microscopi
reveal
abnorm
anim
similar
observ
administr
endotoxin
furthermor
shown
abund
cellular
debri
result
necrosi
sinusoid
cell
obstruct
sinusoid
aggrav
microcirculatori
disturb
mccuskey
leukotrien
could
also
exert
deleteri
effect
increas
permeabl
sinusoid
facilit
migrat
neutrophil
macrophag
liver
parenchyma
andor
activ
inflammatori
cell
fordhutchinson
lewi
austen
samuelsson
et
al
contribut
sinusoid
cell
andor
microvascular
factor
liver
injuri
induc
toxic
agent
also
explor
galactosamin
administr
galactosamin
anim
speci
usual
induc
acut
hepat
within
hr
histolog
featur
similar
observ
patient
viral
hepat
lesion
consist
foci
parenchym
necrosi
dissemin
liver
lobul
surround
inflammatori
infiltr
mainli
compos
polymorphonuclear
cell
lymphocyt
decker
keppler
mechan
liver
injuri
extens
studi
decker
keppler
administr
galactosamin
lead
format
udpderiv
galactosamin
togeth
deplet
utp
udphexos
hepatocyt
produc
inhibit
macromolecul
synthesi
depend
uracil
nucleotid
lesion
cellular
organel
final
cell
necrosi
major
argument
support
hypothesi
prevent
liver
injuri
uridin
given
hr
follow
galactosamin
administr
furthermor
vitro
galactosamin
direct
cytotox
effect
isol
cultur
hepatocyt
data
indic
hepatotox
galactosamin
vivo
may
result
direct
cytotox
effect
hepatocyt
howev
also
evid
circul
endotoxin
hepat
macrophag
could
involv
pathogenesi
liver
injuri
discuss
previous
liver
damag
induc
galactosamin
significantli
increas
administr
endotoxin
galano
et
al
convers
liver
lesion
markedli
reduc
prior
colectomi
perform
nolan
cohen
furthermor
inhibit
kupffer
cell
methylpalmit
ai
tuwaijri
et
al
administr
latex
particl
administr
galactosamin
shiratori
et
al
significantli
decreas
liver
injuri
contrast
necrosi
significantli
increas
kupffer
cell
stimul
latex
particl
administr
galactosamin
shiratori
et
al
data
suggest
activ
kupffer
cell
circul
endotoxin
play
major
role
pathogenesi
parenchym
necrosi
furthermor
hepatoprotect
effect
superoxid
dismutas
suggest
liver
lesion
could
mediat
oxygenderiv
free
radic
releas
macrophag
addit
argument
provid
chojkier
fierer
shown
strain
mice
resist
endotoxin
also
partial
resist
galactosamin
furthermor
transfer
splenic
macrophag
isol
suscept
anim
resist
irradi
anim
induc
suscept
galactosamin
suggest
parenchym
necrosi
induc
galactosamin
result
least
part
activ
hepat
macrophag
accordingli
possibl
protect
effect
prostaglandin
analog
dimethylpg
stachura
et
al
pgi
noda
et
al
pgd
model
could
relat
inhibitori
effect
liver
macrophag
gener
inflammatori
reaction
bray
grygelwski
et
al
ogawa
et
al
mullerberghau
et
al
shown
fibrin
microthrombi
form
sinusoid
galactosamineinduc
hepat
rabbit
administr
heparin
prevent
format
microthrombi
affect
liver
lesion
anim
surviv
indic
activ
coagul
process
occur
sinusoid
galactosamineinduc
hepat
phenomenon
contribut
significantli
liver
injuri
carbon
tetrachlorid
administr
eel
induc
parenchym
necrosi
predomin
periven
region
lesion
accompani
inflammatori
infiltr
consist
polymorphonuclear
mononuclear
cell
fatti
chang
sometim
extens
zimmerman
lesion
usual
maxim
hr
hepat
injuri
probabl
first
model
microcirculatori
factor
consid
play
role
cell
necrosi
earli
concept
attribut
hepat
necrosi
centrilobular
ischemia
secondari
decreas
sinusoid
flow
earli
transillumin
studi
provid
evid
microcircul
impair
intox
subsequ
studi
show
microcirculatori
disturb
occur
centrilobular
injuri
brauer
furthermor
demonstr
brauer
isol
perfus
rat
liver
administr
led
centrilobular
necrosi
even
blood
flow
revers
indic
clearli
necrosi
independ
vascular
chang
inde
preced
latter
sever
hour
gener
thought
hepatotox
occur
via
direct
cytotox
effect
hepatocyt
number
studi
indic
toxic
relat
convers
cytochrom
highli
reactiv
trichloromethyl
radic
ander
howev
brauer
recogn
cell
necrosi
result
direct
cytotox
effect
emphas
impair
microcircul
could
lead
tissu
ischemia
thu
liver
injuri
mechan
could
account
find
liver
lesion
produc
eel
administr
greatli
reduc
procedur
interfer
sympathet
activ
zimmerman
inde
conceiv
liver
vasoconstrict
induc
sympathet
activ
could
contribut
microcirculatori
disturb
observ
administr
howev
altern
mechan
propos
ie
cytotox
effect
catecholamin
result
convers
free
radic
singal
et
al
b
deplet
hepat
glutathion
result
stimul
glutathion
cellular
efflux
catecholamin
sie
graf
recent
studi
suggest
endotoxin
could
also
contribut
liver
damag
develop
endotoxin
toler
administr
polymyxin
b
significantli
reduc
extent
liver
lesion
furthermor
nolan
cohen
shown
endotoxin
clearanc
significantli
reduc
administr
eel
suggest
sinusoid
cell
could
injur
model
contrast
fujiwara
et
al
b
found
neither
sinusoid
lesion
fibrin
microthrombu
format
furthermor
administr
antithrombin
iii
significantli
modifi
liver
damag
data
suggest
lesion
sinusoid
activ
coagul
primari
event
pathogenesi
liver
lesion
model
prostaglandin
analog
dmpge
shown
hepatoprotect
properti
liver
injuri
guarner
et
al
rush
et
al
stachura
et
al
suggest
protect
offer
prostaglandin
could
result
effect
liver
microcircul
howev
shown
dmpge
decreas
format
reactiv
metabolit
cci
rush
et
al
furthermor
prostaglandin
shown
prevent
cytotox
cci
isol
cultur
hepatocyt
bang
et
al
therefor
altern
mechan
directli
involv
liver
microvasculatur
could
account
effect
prostaglandin
model
recent
data
suggest
microcirculatori
factor
could
play
role
hepat
injuri
induc
acetaminophen
jaeschk
mitchel
report
hepat
injuri
produc
mice
aryl
metabolit
acetaminophen
lead
rapid
increas
neutrophil
accumul
consequ
plug
hepat
microvasculatur
suggest
secondari
microcirculatori
chang
exacerb
origin
injuri
expand
region
necrosi
ischem
infarct
periacin
region
interestingli
compon
injuri
prevent
treatment
antioxid
ailopurinol
without
decreas
format
toxic
metabolit
acetaminophen
prevent
glutathion
deplet
fujiwara
et
al
recent
show
lesion
endotheli
fatstor
cell
togeth
fibrin
microthrombi
format
sinusoid
occur
model
acut
liver
damag
induc
dimethylnitrosamin
rat
liver
injuri
accompani
increas
plasma
concentr
solubl
fibrin
monom
complex
decreas
concentr
antithrombin
iii
coagul
factor
viiic
administr
antithrombin
iii
significantli
decreas
liver
injuri
prevent
intravascular
coagul
suggest
causeeffect
relationship
conclus
abnorm
microcircul
sinusoid
cell
function
occur
sever
type
acut
liver
injuri
rais
question
role
modif
hepatocyt
injuri
although
sever
find
suggest
ischem
hypox
liver
injuri
hepat
induc
fv
lesion
microvasculatur
could
primari
event
lead
hepatocyt
injuri
evid
indic
type
liver
damag
primari
liver
lesion
independ
microcirculatori
factor
howev
emphas
brauer
viciou
circl
liver
injuri
caus
impair
hepat
blood
suppli
caus
liver
injuri
caus
yet
circulatori
embarrass
tissu
death
resolut
event
break
cycl
sinc
brauer
recogn
sinusoid
repres
much
complex
system
passiv
channel
ensur
dispers
molecul
sinusoid
cell
form
complex
network
protect
regul
parenchym
cell
multipl
lipid
mediat
cytokin
sinusoid
cell
particularli
kupffer
cell
also
potenti
caus
injuri
releas
cytotox
substanc
activ
coagul
process
recruit
inflammatori
cell
howev
delic
feedback
mechan
exist
differ
cell
type
maintain
equilibrium
cytotox
inhibitori
mechan
disturb
regul
system
excess
stimul
mediat
critic
reduct
inhibitori
factor
caus
amplifi
tissu
injuri
concept
liver
injuri
consequ
singl
factor
result
disturb
regulatori
network
recogn
popper
popper
state
respons
injuri
experiment
anim
human
usual
onestep
reaction
even
seri
stepwis
reaction
cascad
rather
network
interact
event
influenc
regulatori
factor
mediat
secondari
messeng
transduc
signal
determin
respons
hypothesi
correct
complex
multicompon
natur
process
suggest
success
therapeut
strategi
may
consist
combin
drug
rather
singl
pharmacolog
agent
direct
put
key
mechan
eg
mediat
antagonist
final
biolog
physiolog
research
reveal
exist
system
increas
complex
becom
essenti
order
understand
modul
complex
dynam
behavior
system
develop
new
theori
new
model
opinion
author
major
challeng
investig
end
twentieth
centuri
